US3090753A - Ester oil compositions containing acid anhydride - Google Patents

Ester oil compositions containing acid anhydride Download PDF

Info

Publication number
US3090753A
US3090753A US46878A US4687860A US3090753A US 3090753 A US3090753 A US 3090753A US 46878 A US46878 A US 46878A US 4687860 A US4687860 A US 4687860A US 3090753 A US3090753 A US 3090753A
Authority
US
United States
Prior art keywords
percent
glycol
adipate
anhydride
titanate
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
US46878A
Inventor
Alfred H Matuszak
George J Allen
Stephen J Metro
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
ExxonMobil Technology and Engineering Co
Original Assignee
Exxon Research and Engineering Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Exxon Research and Engineering Co filed Critical Exxon Research and Engineering Co
Priority to US46878A priority Critical patent/US3090753A/en
Priority to GB22428/61A priority patent/GB947609A/en
Application granted granted Critical
Publication of US3090753A publication Critical patent/US3090753A/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C10PETROLEUM, GAS OR COKE INDUSTRIES; TECHNICAL GASES CONTAINING CARBON MONOXIDE; FUELS; LUBRICANTS; PEAT
    • C10MLUBRICATING COMPOSITIONS; USE OF CHEMICAL SUBSTANCES EITHER ALONE OR AS LUBRICATING INGREDIENTS IN A LUBRICATING COMPOSITION
    • C10M3/00Liquid compositions essentially based on lubricating components other than mineral lubricating oils or fatty oils and their use as lubricants; Use as lubricants of single liquid substances
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C67/00Preparation of carboxylic acid esters
    • C07C67/48Separation; Purification; Stabilisation; Use of additives
    • C07C67/62Use of additives, e.g. for stabilisation
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/34Esters of acyclic saturated polycarboxylic acids having an esterified carboxyl group bound to an acyclic carbon atom
    • C07C69/44Adipic acid esters
    • CCHEMISTRY; METALLURGY
    • C10PETROLEUM, GAS OR COKE INDUSTRIES; TECHNICAL GASES CONTAINING CARBON MONOXIDE; FUELS; LUBRICANTS; PEAT
    • C10MLUBRICATING COMPOSITIONS; USE OF CHEMICAL SUBSTANCES EITHER ALONE OR AS LUBRICATING INGREDIENTS IN A LUBRICATING COMPOSITION
    • C10M2205/00Organic macromolecular hydrocarbon compounds or fractions, whether or not modified by oxidation as ingredients in lubricant compositions
    • C10M2205/04Organic macromolecular hydrocarbon compounds or fractions, whether or not modified by oxidation as ingredients in lubricant compositions containing aromatic monomers, e.g. styrene
    • CCHEMISTRY; METALLURGY
    • C10PETROLEUM, GAS OR COKE INDUSTRIES; TECHNICAL GASES CONTAINING CARBON MONOXIDE; FUELS; LUBRICANTS; PEAT
    • C10MLUBRICATING COMPOSITIONS; USE OF CHEMICAL SUBSTANCES EITHER ALONE OR AS LUBRICATING INGREDIENTS IN A LUBRICATING COMPOSITION
    • C10M2207/00Organic non-macromolecular hydrocarbon compounds containing hydrogen, carbon and oxygen as ingredients in lubricant compositions
    • C10M2207/10Carboxylix acids; Neutral salts thereof
    • C10M2207/12Carboxylix acids; Neutral salts thereof having carboxyl groups bound to acyclic or cycloaliphatic carbon atoms
    • C10M2207/121Carboxylix acids; Neutral salts thereof having carboxyl groups bound to acyclic or cycloaliphatic carbon atoms having hydrocarbon chains of seven or less carbon atoms
    • C10M2207/123Carboxylix acids; Neutral salts thereof having carboxyl groups bound to acyclic or cycloaliphatic carbon atoms having hydrocarbon chains of seven or less carbon atoms polycarboxylic
    • CCHEMISTRY; METALLURGY
    • C10PETROLEUM, GAS OR COKE INDUSTRIES; TECHNICAL GASES CONTAINING CARBON MONOXIDE; FUELS; LUBRICANTS; PEAT
    • C10MLUBRICATING COMPOSITIONS; USE OF CHEMICAL SUBSTANCES EITHER ALONE OR AS LUBRICATING INGREDIENTS IN A LUBRICATING COMPOSITION
    • C10M2207/00Organic non-macromolecular hydrocarbon compounds containing hydrogen, carbon and oxygen as ingredients in lubricant compositions
    • C10M2207/10Carboxylix acids; Neutral salts thereof
    • C10M2207/12Carboxylix acids; Neutral salts thereof having carboxyl groups bound to acyclic or cycloaliphatic carbon atoms
    • C10M2207/129Carboxylix acids; Neutral salts thereof having carboxyl groups bound to acyclic or cycloaliphatic carbon atoms having hydrocarbon chains of thirty or more carbon atoms
    • CCHEMISTRY; METALLURGY
    • C10PETROLEUM, GAS OR COKE INDUSTRIES; TECHNICAL GASES CONTAINING CARBON MONOXIDE; FUELS; LUBRICANTS; PEAT
    • C10MLUBRICATING COMPOSITIONS; USE OF CHEMICAL SUBSTANCES EITHER ALONE OR AS LUBRICATING INGREDIENTS IN A LUBRICATING COMPOSITION
    • C10M2207/00Organic non-macromolecular hydrocarbon compounds containing hydrogen, carbon and oxygen as ingredients in lubricant compositions
    • C10M2207/10Carboxylix acids; Neutral salts thereof
    • C10M2207/14Carboxylix acids; Neutral salts thereof having carboxyl groups bound to carbon atoms of six-membered aromatic rings
    • CCHEMISTRY; METALLURGY
    • C10PETROLEUM, GAS OR COKE INDUSTRIES; TECHNICAL GASES CONTAINING CARBON MONOXIDE; FUELS; LUBRICANTS; PEAT
    • C10MLUBRICATING COMPOSITIONS; USE OF CHEMICAL SUBSTANCES EITHER ALONE OR AS LUBRICATING INGREDIENTS IN A LUBRICATING COMPOSITION
    • C10M2207/00Organic non-macromolecular hydrocarbon compounds containing hydrogen, carbon and oxygen as ingredients in lubricant compositions
    • C10M2207/10Carboxylix acids; Neutral salts thereof
    • C10M2207/14Carboxylix acids; Neutral salts thereof having carboxyl groups bound to carbon atoms of six-membered aromatic rings
    • C10M2207/142Carboxylix acids; Neutral salts thereof having carboxyl groups bound to carbon atoms of six-membered aromatic rings polycarboxylic
    • CCHEMISTRY; METALLURGY
    • C10PETROLEUM, GAS OR COKE INDUSTRIES; TECHNICAL GASES CONTAINING CARBON MONOXIDE; FUELS; LUBRICANTS; PEAT
    • C10MLUBRICATING COMPOSITIONS; USE OF CHEMICAL SUBSTANCES EITHER ALONE OR AS LUBRICATING INGREDIENTS IN A LUBRICATING COMPOSITION
    • C10M2207/00Organic non-macromolecular hydrocarbon compounds containing hydrogen, carbon and oxygen as ingredients in lubricant compositions
    • C10M2207/10Carboxylix acids; Neutral salts thereof
    • C10M2207/22Acids obtained from polymerised unsaturated acids
    • CCHEMISTRY; METALLURGY
    • C10PETROLEUM, GAS OR COKE INDUSTRIES; TECHNICAL GASES CONTAINING CARBON MONOXIDE; FUELS; LUBRICANTS; PEAT
    • C10MLUBRICATING COMPOSITIONS; USE OF CHEMICAL SUBSTANCES EITHER ALONE OR AS LUBRICATING INGREDIENTS IN A LUBRICATING COMPOSITION
    • C10M2207/00Organic non-macromolecular hydrocarbon compounds containing hydrogen, carbon and oxygen as ingredients in lubricant compositions
    • C10M2207/28Esters
    • C10M2207/281Esters of (cyclo)aliphatic monocarboxylic acids
    • CCHEMISTRY; METALLURGY
    • C10PETROLEUM, GAS OR COKE INDUSTRIES; TECHNICAL GASES CONTAINING CARBON MONOXIDE; FUELS; LUBRICANTS; PEAT
    • C10MLUBRICATING COMPOSITIONS; USE OF CHEMICAL SUBSTANCES EITHER ALONE OR AS LUBRICATING INGREDIENTS IN A LUBRICATING COMPOSITION
    • C10M2207/00Organic non-macromolecular hydrocarbon compounds containing hydrogen, carbon and oxygen as ingredients in lubricant compositions
    • C10M2207/28Esters
    • C10M2207/282Esters of (cyclo)aliphatic oolycarboxylic acids
    • CCHEMISTRY; METALLURGY
    • C10PETROLEUM, GAS OR COKE INDUSTRIES; TECHNICAL GASES CONTAINING CARBON MONOXIDE; FUELS; LUBRICANTS; PEAT
    • C10MLUBRICATING COMPOSITIONS; USE OF CHEMICAL SUBSTANCES EITHER ALONE OR AS LUBRICATING INGREDIENTS IN A LUBRICATING COMPOSITION
    • C10M2207/00Organic non-macromolecular hydrocarbon compounds containing hydrogen, carbon and oxygen as ingredients in lubricant compositions
    • C10M2207/28Esters
    • C10M2207/283Esters of polyhydroxy compounds
    • CCHEMISTRY; METALLURGY
    • C10PETROLEUM, GAS OR COKE INDUSTRIES; TECHNICAL GASES CONTAINING CARBON MONOXIDE; FUELS; LUBRICANTS; PEAT
    • C10MLUBRICATING COMPOSITIONS; USE OF CHEMICAL SUBSTANCES EITHER ALONE OR AS LUBRICATING INGREDIENTS IN A LUBRICATING COMPOSITION
    • C10M2207/00Organic non-macromolecular hydrocarbon compounds containing hydrogen, carbon and oxygen as ingredients in lubricant compositions
    • C10M2207/28Esters
    • C10M2207/286Esters of polymerised unsaturated acids
    • CCHEMISTRY; METALLURGY
    • C10PETROLEUM, GAS OR COKE INDUSTRIES; TECHNICAL GASES CONTAINING CARBON MONOXIDE; FUELS; LUBRICANTS; PEAT
    • C10MLUBRICATING COMPOSITIONS; USE OF CHEMICAL SUBSTANCES EITHER ALONE OR AS LUBRICATING INGREDIENTS IN A LUBRICATING COMPOSITION
    • C10M2207/00Organic non-macromolecular hydrocarbon compounds containing hydrogen, carbon and oxygen as ingredients in lubricant compositions
    • C10M2207/28Esters
    • C10M2207/30Complex esters, i.e. compounds containing at leasst three esterified carboxyl groups and derived from the combination of at least three different types of the following five types of compounds: monohydroxyl compounds, polyhydroxy xompounds, monocarboxylic acids, polycarboxylic acids or hydroxy carboxylic acids
    • CCHEMISTRY; METALLURGY
    • C10PETROLEUM, GAS OR COKE INDUSTRIES; TECHNICAL GASES CONTAINING CARBON MONOXIDE; FUELS; LUBRICANTS; PEAT
    • C10MLUBRICATING COMPOSITIONS; USE OF CHEMICAL SUBSTANCES EITHER ALONE OR AS LUBRICATING INGREDIENTS IN A LUBRICATING COMPOSITION
    • C10M2207/00Organic non-macromolecular hydrocarbon compounds containing hydrogen, carbon and oxygen as ingredients in lubricant compositions
    • C10M2207/28Esters
    • C10M2207/30Complex esters, i.e. compounds containing at leasst three esterified carboxyl groups and derived from the combination of at least three different types of the following five types of compounds: monohydroxyl compounds, polyhydroxy xompounds, monocarboxylic acids, polycarboxylic acids or hydroxy carboxylic acids
    • C10M2207/302Complex esters, i.e. compounds containing at leasst three esterified carboxyl groups and derived from the combination of at least three different types of the following five types of compounds: monohydroxyl compounds, polyhydroxy xompounds, monocarboxylic acids, polycarboxylic acids or hydroxy carboxylic acids derived from the combination of monocarboxylic acids, dicarboxylic acids and dihydroxy compounds only and having no free hydroxy or carboxyl groups
    • CCHEMISTRY; METALLURGY
    • C10PETROLEUM, GAS OR COKE INDUSTRIES; TECHNICAL GASES CONTAINING CARBON MONOXIDE; FUELS; LUBRICANTS; PEAT
    • C10MLUBRICATING COMPOSITIONS; USE OF CHEMICAL SUBSTANCES EITHER ALONE OR AS LUBRICATING INGREDIENTS IN A LUBRICATING COMPOSITION
    • C10M2207/00Organic non-macromolecular hydrocarbon compounds containing hydrogen, carbon and oxygen as ingredients in lubricant compositions
    • C10M2207/28Esters
    • C10M2207/30Complex esters, i.e. compounds containing at leasst three esterified carboxyl groups and derived from the combination of at least three different types of the following five types of compounds: monohydroxyl compounds, polyhydroxy xompounds, monocarboxylic acids, polycarboxylic acids or hydroxy carboxylic acids
    • C10M2207/304Complex esters, i.e. compounds containing at leasst three esterified carboxyl groups and derived from the combination of at least three different types of the following five types of compounds: monohydroxyl compounds, polyhydroxy xompounds, monocarboxylic acids, polycarboxylic acids or hydroxy carboxylic acids derived from the combination of monohydroxy compounds, dihydroxy compounds and dicarboxylic acids only and having no free hydroxy or carboxyl groups
    • CCHEMISTRY; METALLURGY
    • C10PETROLEUM, GAS OR COKE INDUSTRIES; TECHNICAL GASES CONTAINING CARBON MONOXIDE; FUELS; LUBRICANTS; PEAT
    • C10MLUBRICATING COMPOSITIONS; USE OF CHEMICAL SUBSTANCES EITHER ALONE OR AS LUBRICATING INGREDIENTS IN A LUBRICATING COMPOSITION
    • C10M2207/00Organic non-macromolecular hydrocarbon compounds containing hydrogen, carbon and oxygen as ingredients in lubricant compositions
    • C10M2207/28Esters
    • C10M2207/34Esters having a hydrocarbon substituent of thirty or more carbon atoms, e.g. substituted succinic acid derivatives
    • CCHEMISTRY; METALLURGY
    • C10PETROLEUM, GAS OR COKE INDUSTRIES; TECHNICAL GASES CONTAINING CARBON MONOXIDE; FUELS; LUBRICANTS; PEAT
    • C10MLUBRICATING COMPOSITIONS; USE OF CHEMICAL SUBSTANCES EITHER ALONE OR AS LUBRICATING INGREDIENTS IN A LUBRICATING COMPOSITION
    • C10M2209/00Organic macromolecular compounds containing oxygen as ingredients in lubricant compositions
    • C10M2209/02Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds
    • C10M2209/08Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds containing monomers having an unsaturated radical bound to a carboxyl radical, e.g. acrylate type
    • C10M2209/084Acrylate; Methacrylate
    • CCHEMISTRY; METALLURGY
    • C10PETROLEUM, GAS OR COKE INDUSTRIES; TECHNICAL GASES CONTAINING CARBON MONOXIDE; FUELS; LUBRICANTS; PEAT
    • C10MLUBRICATING COMPOSITIONS; USE OF CHEMICAL SUBSTANCES EITHER ALONE OR AS LUBRICATING INGREDIENTS IN A LUBRICATING COMPOSITION
    • C10M2209/00Organic macromolecular compounds containing oxygen as ingredients in lubricant compositions
    • C10M2209/10Macromolecular compoundss obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds
    • C10M2209/103Polyethers, i.e. containing di- or higher polyoxyalkylene groups
    • C10M2209/104Polyethers, i.e. containing di- or higher polyoxyalkylene groups of alkylene oxides containing two carbon atoms only
    • CCHEMISTRY; METALLURGY
    • C10PETROLEUM, GAS OR COKE INDUSTRIES; TECHNICAL GASES CONTAINING CARBON MONOXIDE; FUELS; LUBRICANTS; PEAT
    • C10MLUBRICATING COMPOSITIONS; USE OF CHEMICAL SUBSTANCES EITHER ALONE OR AS LUBRICATING INGREDIENTS IN A LUBRICATING COMPOSITION
    • C10M2209/00Organic macromolecular compounds containing oxygen as ingredients in lubricant compositions
    • C10M2209/10Macromolecular compoundss obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds
    • C10M2209/103Polyethers, i.e. containing di- or higher polyoxyalkylene groups
    • C10M2209/105Polyethers, i.e. containing di- or higher polyoxyalkylene groups of alkylene oxides containing three carbon atoms only
    • CCHEMISTRY; METALLURGY
    • C10PETROLEUM, GAS OR COKE INDUSTRIES; TECHNICAL GASES CONTAINING CARBON MONOXIDE; FUELS; LUBRICANTS; PEAT
    • C10MLUBRICATING COMPOSITIONS; USE OF CHEMICAL SUBSTANCES EITHER ALONE OR AS LUBRICATING INGREDIENTS IN A LUBRICATING COMPOSITION
    • C10M2209/00Organic macromolecular compounds containing oxygen as ingredients in lubricant compositions
    • C10M2209/10Macromolecular compoundss obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds
    • C10M2209/11Complex polyesters
    • CCHEMISTRY; METALLURGY
    • C10PETROLEUM, GAS OR COKE INDUSTRIES; TECHNICAL GASES CONTAINING CARBON MONOXIDE; FUELS; LUBRICANTS; PEAT
    • C10MLUBRICATING COMPOSITIONS; USE OF CHEMICAL SUBSTANCES EITHER ALONE OR AS LUBRICATING INGREDIENTS IN A LUBRICATING COMPOSITION
    • C10M2209/00Organic macromolecular compounds containing oxygen as ingredients in lubricant compositions
    • C10M2209/10Macromolecular compoundss obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds
    • C10M2209/11Complex polyesters
    • C10M2209/111Complex polyesters having dicarboxylic acid centres
    • CCHEMISTRY; METALLURGY
    • C10PETROLEUM, GAS OR COKE INDUSTRIES; TECHNICAL GASES CONTAINING CARBON MONOXIDE; FUELS; LUBRICANTS; PEAT
    • C10MLUBRICATING COMPOSITIONS; USE OF CHEMICAL SUBSTANCES EITHER ALONE OR AS LUBRICATING INGREDIENTS IN A LUBRICATING COMPOSITION
    • C10M2209/00Organic macromolecular compounds containing oxygen as ingredients in lubricant compositions
    • C10M2209/10Macromolecular compoundss obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds
    • C10M2209/11Complex polyesters
    • C10M2209/112Complex polyesters having dihydric acid centres
    • CCHEMISTRY; METALLURGY
    • C10PETROLEUM, GAS OR COKE INDUSTRIES; TECHNICAL GASES CONTAINING CARBON MONOXIDE; FUELS; LUBRICANTS; PEAT
    • C10MLUBRICATING COMPOSITIONS; USE OF CHEMICAL SUBSTANCES EITHER ALONE OR AS LUBRICATING INGREDIENTS IN A LUBRICATING COMPOSITION
    • C10M2215/00Organic non-macromolecular compounds containing nitrogen as ingredients in lubricant compositions
    • C10M2215/02Amines, e.g. polyalkylene polyamines; Quaternary amines
    • C10M2215/06Amines, e.g. polyalkylene polyamines; Quaternary amines having amino groups bound to carbon atoms of six-membered aromatic rings
    • C10M2215/064Di- and triaryl amines
    • CCHEMISTRY; METALLURGY
    • C10PETROLEUM, GAS OR COKE INDUSTRIES; TECHNICAL GASES CONTAINING CARBON MONOXIDE; FUELS; LUBRICANTS; PEAT
    • C10MLUBRICATING COMPOSITIONS; USE OF CHEMICAL SUBSTANCES EITHER ALONE OR AS LUBRICATING INGREDIENTS IN A LUBRICATING COMPOSITION
    • C10M2215/00Organic non-macromolecular compounds containing nitrogen as ingredients in lubricant compositions
    • C10M2215/02Amines, e.g. polyalkylene polyamines; Quaternary amines
    • C10M2215/06Amines, e.g. polyalkylene polyamines; Quaternary amines having amino groups bound to carbon atoms of six-membered aromatic rings
    • C10M2215/064Di- and triaryl amines
    • C10M2215/065Phenyl-Naphthyl amines
    • CCHEMISTRY; METALLURGY
    • C10PETROLEUM, GAS OR COKE INDUSTRIES; TECHNICAL GASES CONTAINING CARBON MONOXIDE; FUELS; LUBRICANTS; PEAT
    • C10MLUBRICATING COMPOSITIONS; USE OF CHEMICAL SUBSTANCES EITHER ALONE OR AS LUBRICATING INGREDIENTS IN A LUBRICATING COMPOSITION
    • C10M2215/00Organic non-macromolecular compounds containing nitrogen as ingredients in lubricant compositions
    • C10M2215/02Amines, e.g. polyalkylene polyamines; Quaternary amines
    • C10M2215/06Amines, e.g. polyalkylene polyamines; Quaternary amines having amino groups bound to carbon atoms of six-membered aromatic rings
    • C10M2215/066Arylene diamines
    • CCHEMISTRY; METALLURGY
    • C10PETROLEUM, GAS OR COKE INDUSTRIES; TECHNICAL GASES CONTAINING CARBON MONOXIDE; FUELS; LUBRICANTS; PEAT
    • C10MLUBRICATING COMPOSITIONS; USE OF CHEMICAL SUBSTANCES EITHER ALONE OR AS LUBRICATING INGREDIENTS IN A LUBRICATING COMPOSITION
    • C10M2219/00Organic non-macromolecular compounds containing sulfur, selenium or tellurium as ingredients in lubricant compositions
    • C10M2219/10Heterocyclic compounds containing sulfur, selenium or tellurium compounds in the ring
    • C10M2219/104Heterocyclic compounds containing sulfur, selenium or tellurium compounds in the ring containing sulfur and carbon with nitrogen or oxygen in the ring
    • C10M2219/108Phenothiazine
    • CCHEMISTRY; METALLURGY
    • C10PETROLEUM, GAS OR COKE INDUSTRIES; TECHNICAL GASES CONTAINING CARBON MONOXIDE; FUELS; LUBRICANTS; PEAT
    • C10MLUBRICATING COMPOSITIONS; USE OF CHEMICAL SUBSTANCES EITHER ALONE OR AS LUBRICATING INGREDIENTS IN A LUBRICATING COMPOSITION
    • C10M2221/00Organic macromolecular compounds containing sulfur, selenium or tellurium as ingredients in lubricant compositions
    • C10M2221/04Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds
    • C10M2221/043Polyoxyalkylene ethers with a thioether group
    • CCHEMISTRY; METALLURGY
    • C10PETROLEUM, GAS OR COKE INDUSTRIES; TECHNICAL GASES CONTAINING CARBON MONOXIDE; FUELS; LUBRICANTS; PEAT
    • C10MLUBRICATING COMPOSITIONS; USE OF CHEMICAL SUBSTANCES EITHER ALONE OR AS LUBRICATING INGREDIENTS IN A LUBRICATING COMPOSITION
    • C10M2223/00Organic non-macromolecular compounds containing phosphorus as ingredients in lubricant compositions
    • C10M2223/02Organic non-macromolecular compounds containing phosphorus as ingredients in lubricant compositions having no phosphorus-to-carbon bonds
    • C10M2223/04Phosphate esters
    • C10M2223/041Triaryl phosphates
    • CCHEMISTRY; METALLURGY
    • C10PETROLEUM, GAS OR COKE INDUSTRIES; TECHNICAL GASES CONTAINING CARBON MONOXIDE; FUELS; LUBRICANTS; PEAT
    • C10MLUBRICATING COMPOSITIONS; USE OF CHEMICAL SUBSTANCES EITHER ALONE OR AS LUBRICATING INGREDIENTS IN A LUBRICATING COMPOSITION
    • C10M2227/00Organic non-macromolecular compounds containing atoms of elements not provided for in groups C10M2203/00, C10M2207/00, C10M2211/00, C10M2215/00, C10M2219/00 or C10M2223/00 as ingredients in lubricant compositions
    • C10M2227/06Organic compounds derived from inorganic acids or metal salts
    • C10M2227/065Organic compounds derived from inorganic acids or metal salts derived from Ti or Zr
    • CCHEMISTRY; METALLURGY
    • C10PETROLEUM, GAS OR COKE INDUSTRIES; TECHNICAL GASES CONTAINING CARBON MONOXIDE; FUELS; LUBRICANTS; PEAT
    • C10MLUBRICATING COMPOSITIONS; USE OF CHEMICAL SUBSTANCES EITHER ALONE OR AS LUBRICATING INGREDIENTS IN A LUBRICATING COMPOSITION
    • C10M2229/00Organic macromolecular compounds containing atoms of elements not provided for in groups C10M2205/00, C10M2209/00, C10M2213/00, C10M2217/00, C10M2221/00 or C10M2225/00 as ingredients in lubricant compositions
    • C10M2229/04Siloxanes with specific structure
    • C10M2229/041Siloxanes with specific structure containing aliphatic substituents
    • CCHEMISTRY; METALLURGY
    • C10PETROLEUM, GAS OR COKE INDUSTRIES; TECHNICAL GASES CONTAINING CARBON MONOXIDE; FUELS; LUBRICANTS; PEAT
    • C10NINDEXING SCHEME ASSOCIATED WITH SUBCLASS C10M RELATING TO LUBRICATING COMPOSITIONS
    • C10N2030/00Specified physical or chemical properties which is improved by the additive characterising the lubricating composition, e.g. multifunctional additives
    • C10N2030/08Resistance to extreme temperature
    • CCHEMISTRY; METALLURGY
    • C10PETROLEUM, GAS OR COKE INDUSTRIES; TECHNICAL GASES CONTAINING CARBON MONOXIDE; FUELS; LUBRICANTS; PEAT
    • C10NINDEXING SCHEME ASSOCIATED WITH SUBCLASS C10M RELATING TO LUBRICATING COMPOSITIONS
    • C10N2040/00Specified use or application for which the lubricating composition is intended
    • C10N2040/12Gas-turbines
    • CCHEMISTRY; METALLURGY
    • C10PETROLEUM, GAS OR COKE INDUSTRIES; TECHNICAL GASES CONTAINING CARBON MONOXIDE; FUELS; LUBRICANTS; PEAT
    • C10NINDEXING SCHEME ASSOCIATED WITH SUBCLASS C10M RELATING TO LUBRICATING COMPOSITIONS
    • C10N2040/00Specified use or application for which the lubricating composition is intended
    • C10N2040/12Gas-turbines
    • C10N2040/13Aircraft turbines

Definitions

  • the synthetic ester lubricating oils are widely used in the formation of lubricants for aircraft engines such as turbo-jet, turboprop and pure-jet aircraft.
  • lead-containing bearings are used and unfortunately, the synthetic esters per se are corrosive to such bearings.
  • the present invention resides in the discovery that acid auhydrides may be directly added to ester oils in order to inhibit lead corrosion.
  • the anhydrides do not detract from the other desirable properties of the ester oil. In fact, the anhydrides tend to enhance other important properties of the composition, particularly the load-carrying ability of the oil.
  • the acid anhydrides of the invention include monoor dianhydn'des of carboxylic acids, particularly of hydrocarbon acids, i.e. where the entire molecule is made up of carbon and hydrogen except for the oxygen of the anhydride portions, containing about 8 to 50, preferably 8 to 30 carbon atoms per molecule.
  • Such anhydrides will include those of aromatic, alicyclic, aliphatic, alkaryl, and other acids.
  • Examples of these anhydrides include pyromellitic dianhydride, alkenyl succinic anhydride, phthalic anhydride, dialkyl pyromellitic monoanhydride, hemimellitic 'anhydridc, trimellitic 'anhydride, naphthalic anhydride (1,8), prehnitic dianhydride, diphenic anhydride, and mellitic dianhyd-ride.
  • the lubricants of the invention will comprise a major amount of an ester oil and dissolved therein, about 0.001 to 5.0 Wt. percent, preferably 0.01 to 2. wt. percent, based upon the total amount of the lubricant, of anhydride.
  • ester oils operable as base oils in the compositions of this invention comprise hydrocarbon chains interruped with 2 to 10 ester linkages, and which can be further interrupted with ether or thioether linkages. Included are diesters, polyesters, and complex esters.
  • the diesters are generally prepared from dicarboxylic acids fully esterified with monohydric alcohols, or from glycols fully esterified with rnonocarboxylic acids.
  • the total number of carbon atoms in the diester molecule is generally about 18 to 36, preferably 20 to 28..
  • Preferred dicarboxylic diesters are those of the formula:
  • each R may be the same or different and represents the straight or branched chain alkyl radical of a monohydric alcohol having about 6 to 13 carbon atoms, While R is a straight or branched chain C to C divalent saturated aliphatic hydrocarbon radical.
  • diesters examples include: di-2-ethylhexyl sebacate, di-C Oxo sebacate, di-nonyl sebacate, di-2,2,4-trimethylpentyl 2 sebacate, di-2-ethylhexyl azelate, di-2,2,4-trimethylpentyl azelate, di-C 0x0 azelate, di-n-heptyl isosebacate, di-C OX0 :adipate, ⁇ di-nonyl adipate, di-C 0x0 adipate, di-2- ethylhexyl adipate, mono C Oxo, mono C Oxo adipate, dl-Cq Oxo adipate, di-C trimethyl adipate, di-C Oxo pimelate, etc.
  • diesters are those prepared from glycols and monocarboxylic acids such as dipropylene glycol dipelargonate and polyethylene glycol 200 dicaproate. Diesters prepared the 0x0 alcohols, which are isomeric mixtures of branched chain aliphatic primary alcohols, are particularly desirable. The Oxo alcohols have a very high degree of branching in the hydrocarbon chain, which results in diester oils having low pour points and low visoosities at low temperatures.
  • These alcohols are prepared from olefins, such as polymers and copolymers of C and C monoolefins, which are reacted with carbon monoxide and hydrogen in the presence of a cobalt-containing catalyst such as a cobalt carbonyl, at temperatures of about 300 to 400 F., and under pressures of about 17000 to 3000 psi. to form aldehydes.
  • a cobalt-containing catalyst such as a cobalt carbonyl
  • Operable polyesters are prepared by reacting polyhydric alcohols such as tn'methylolpropane and pentaerythritol with monocarboxylic acids such .as butyric acid, caproic acid, caprylic acid, pelargonic acid, etc. to give the corresponding trior tetraants.
  • polyhydric alcohols such as tn'methylolpropane and pentaerythritol
  • monocarboxylic acids such .as butyric acid, caproic acid, caprylic acid, pelargonic acid, etc.
  • the complex esters which may be used as the base oils are formed by esterification reactions between a di carboxylic acid, a glycol, and an alcohol and/or a monocarboxylic acid. These esters may be represented by the following formulas:
  • R and R are alkyl radicals of a monohydric alcohol or a monocarboxylic acid; R and R are hydrogen radicals of dicarboxylic acids, e.g. alkandioic acids; and R and R are divalent hydrocarbon or hydro carbon-oxy radicals, such as -CH (CH or -CH CH (O CH CH or CH CH CH OCH CH (CH derived from an alkylene glycol or polyalkylene glycol.
  • Some specific materials used in preparing the above types 'of complex esters are as follows: alcohols having 6 to 13 carbon atoms such as nbutyl alcohol, 2-ethylbutyl alcohol, 2-ethylhexano1, n-hexyl alcohol, C Oxo alcohol and C Oxo alcohol, etc.; the corresponding fatty or monocarboxylic acids; C to C dicarboxylic acids such as sebacic, adipic and azelaic; and glycols such as polyethylene glycol.
  • the complex esters will have a total of 20 to 80, preferably 40 to 65, carbon atoms.
  • the composition can also include other additives (e.g. 0.01 to 10.0 wt. percent). Included are oxidation inhibitors such as phenothiazine, dioctyl phenothiazine, dioctyl diphenylamine, phenyl u-naphthylamine, p-amino diphenyl amine; viscosity index improvers such as polymethacrylates, polystyrene; anti-foamant-s such as dimethylsilicone polymers; anti-wear agents such as tricresyl phosphate; load-carrying agents; etc.
  • oxidation inhibitors such as phenothiazine, dioctyl phenothiazine, dioctyl diphenylamine, phenyl u-naphthylamine, p-amino diphenyl amine
  • viscosity index improvers such as polymethacrylates, polys
  • desirable load-carrying agents are various alkylene glycol titanates. These materials may be represented by the general formula:
  • R is an aliphatic radical having from about 3 to 15, and preferably from 6 to 12, carbon atoms. It is, of course, possible for both hydroxyl groups of one glycol to react with two of the acidic groups of titanic acid molecules to form polymeric materials.
  • glycol titanates are for the monoglycol or diglycol titanates, respectively, where R is the aliphatic radical of the glycol as heretofore stated.
  • Alkoxy glycol titanates are also contemplated, represented by the formula:
  • R is the aliphatic radical of the glycol as heretofore stated and R is an aliphatic radical of from 3 to 12 carbon atoms, e.g. dibutoxy di(hexylene glycol) titanate.
  • titanates include hexylene glycol titanate, dodecylene glycol titanate, octylene glycol titanate, and dibutoxy di(hexylene glycol) titanate.
  • Titanates of the preceding types are known in the art and have been described in various patents, e.g. U. S. Patent No. 2,643,262.
  • titanates are preferably used in amounts of 0.01 to 5.0 wt. percent as load-carrying agents. While extremely effective for carrying load, titanates are very corrosive to copper and lead. Although conventional lead and copper corrosion inhibitors were not effective with titanates, the anhydrides of the present invention are efiective.
  • a base oil material was prepared consisting of 100 parts by weight of 50 volume percent of a di-C Oxo adipate and 50 volume wt. percent of di-C Oxo adipate, and 1 part by weight of phenothiazine as an antioxidant.
  • the titanate was a solution of about 30 wt. percent n-butyl alcohol and about 70 wt. percent of tetra- (octylene glycol) titanate prepared by transesterification' of one molar amount of tetra n-butyl titanate with four molar amounts of Z-ethyl-hexane diol. This was a commercial product sold by DuPont under the tradename OGT-41. The resulting blends were then tested for lead corrosion inhibition in accordance with the MILFL- 7808 specification procedure.
  • EXAMPLE II An ester oil mixture was prepared consisting of 50 volume percent di-C 0x0 adipate and 50 volume percent of di-C Oxo adipate. To this oil mixture was added 0.5 wt. percent phenothiazine as antioxidant, and 0.001 wt. percent of a diamethyl silicone having a viscosity of 60,000 cs. at 25 C. as an antifoamant. To this base oil composition was added 0.6 wt. percent of a C alkenyl succinic anhydride having the formula:
  • the base oil composition per se and the base oil composition containing the succinic anhydride were tested in the lead corrosion test previously described above, and in an oxidation-corrosion test which determined the oxidative stability and the corrosivity of the compositions to copper, magnesium, iron, aluminum and silver. These tests were carried out in accordance with MlLL-7808C specification procedures.
  • weighed strips of the metals to be tested were immersed in cc. of the oil sample maintained at 347 F. for 72 hours while 0.5 liter per hour of air was bubbled through the sample. The metal strips were then reweighed to determine the corrosivity of the oil as indicated by the weight change in mg./cm.
  • the oxidative stability of the oil was shown by the change in viscosity and neutralization number of the oil after testing.
  • Adipate Base 50 vol. percent C! 0x0 adipate plus 50 vol. percent 010 0x0 adipate plus 0.5 weight percent phenothiazine plus 0.001 weight percent -200 (60,000 cs.) silicone.
  • EXAMPLE III A base oil composition consisting predominantly of di-C /C OX0 adipate and di-octyl sebacate plus various lubricating oil additives was prepared and stored for six months, during which time it had developed a high corrosivity toward lead. To samples of this highly corrosive base oil were then added phthalic anhydride and pyromellitic anhydride to determine their eifect on reduoing the lead corrosion of the base oil. From the results shown in the following table it will be noted that each anhydride inhibits the lead corrosivity of the base oil but that the pyromellitic dianhydride is more effective than the phthalic anhydride. This is also true when the corrosive oil is stored under high temperature conditions for 14 days.
  • Blend A The blend was prepared, wherein all parts are by weight, by simple mixing of 100 parts of di(2 ethylhexyl) sebacate, 1 part phenothiazine, 0.001 part of silicone anti-foamant and 0.7 part of the solution of complex of octylene glycol titanate and pyromellitic dianhydride.
  • the composition carried 3,765 pound/inch load in the Ryder gear test and showed no corrosion in the lead corrosion test after 12 hours.
  • the sebacate ester without the complex will carry only about 1,900 lb./in. in the Ryder gear test, while the addition to the titanate per se to the ester oil would result in severe lead corrosion.
  • Blend B.-To parts by Weight of a 50/50 volume mixttue of di(C Oxo) adipate and di(C 0x0) adipate was added 0.7 part by weight of phenothiazine and 0.7 part by weight of the solution of complex ti-tanate.
  • This composition carried 3,440 1b./in. load in the Ryder gear test. It also showed only 5.0 mg./in. weight loss in the lead corrosion test at the end of 12 hours, which is within acceptable limits.
  • the present invention includes the addition to lubricating oils of monoand di-anhydrides of the formula: R(X) where R is a hydrocarbon radical, X is the anhydride group and n is one or two. R can also include a carboxylic acid group substituted on the hydrocarbon chain. The total number of carbon atoms in the molecule will be 8 to 50, e.g. 8 to 30.
  • heating the anhydride with alkylene glycol titanates, either mono-, di-, tri-, or tetratitanates or mixtures thereof results in some sort of a complex which is particularly useful as a load-carrying agent with low corrosivity to lead.
  • a synthetic ester lubricating oil composition comprising a major proportion of carboxylic acid ester lubricating oil and about 0.001 to 5.0 wt. percent of pyromellitic dianhydride.
  • a lubricating oil composition comprising a major proportion of diester of the formula:
  • ROOCRCOOR wherein R represents a C to C alkyl radical and R is a C to C aliphatic hydrocarbon radical, and about 0.001

Description

United States Patent Ofi 3,090,753 Patented May 21, 1963 ice 3,090,753 ESTER OIL COMPOSITIONS CONTAINING ACID ANHYDRIDE Alfred H. Matuszak, Westfield, George J. Allen, Roselle,
and Stephen J. Metro, Scotch Plains, N.J., assiguors to Esso Research and Engineering Company, a corporation of Delaware No Drawing. Filed Aug. 2, 1960, Ser. No. 46,878 3 Claims. (Cl. 25242.7)
Because of their utility over extremely wide temperature ranges, the synthetic ester lubricating oils are widely used in the formation of lubricants for aircraft engines such as turbo-jet, turboprop and pure-jet aircraft. In such engines, lead-containing bearings are used and unfortunately, the synthetic esters per se are corrosive to such bearings. The present invention resides in the discovery that acid auhydrides may be directly added to ester oils in order to inhibit lead corrosion. At the same time, the anhydrides do not detract from the other desirable properties of the ester oil. In fact, the anhydrides tend to enhance other important properties of the composition, particularly the load-carrying ability of the oil.
The acid anhydrides of the invention include monoor dianhydn'des of carboxylic acids, particularly of hydrocarbon acids, i.e. where the entire molecule is made up of carbon and hydrogen except for the oxygen of the anhydride portions, containing about 8 to 50, preferably 8 to 30 carbon atoms per molecule. Such anhydrides will include those of aromatic, alicyclic, aliphatic, alkaryl, and other acids. Examples of these anhydrides include pyromellitic dianhydride, alkenyl succinic anhydride, phthalic anhydride, dialkyl pyromellitic monoanhydride, hemimellitic 'anhydridc, trimellitic 'anhydride, naphthalic anhydride (1,8), prehnitic dianhydride, diphenic anhydride, and mellitic dianhyd-ride.
The lubricants of the invention will comprise a major amount of an ester oil and dissolved therein, about 0.001 to 5.0 Wt. percent, preferably 0.01 to 2. wt. percent, based upon the total amount of the lubricant, of anhydride.
The ester oils operable as base oils in the compositions of this invention comprise hydrocarbon chains interruped with 2 to 10 ester linkages, and which can be further interrupted with ether or thioether linkages. Included are diesters, polyesters, and complex esters.
The diesters are generally prepared from dicarboxylic acids fully esterified with monohydric alcohols, or from glycols fully esterified with rnonocarboxylic acids. The total number of carbon atoms in the diester molecule is generally about 18 to 36, preferably 20 to 28.. Preferred dicarboxylic diesters are those of the formula:
wherein each R may be the same or different and represents the straight or branched chain alkyl radical of a monohydric alcohol having about 6 to 13 carbon atoms, While R is a straight or branched chain C to C divalent saturated aliphatic hydrocarbon radical. Examples of such diesters include: di-2-ethylhexyl sebacate, di-C Oxo sebacate, di-nonyl sebacate, di-2,2,4-trimethylpentyl 2 sebacate, di-2-ethylhexyl azelate, di-2,2,4-trimethylpentyl azelate, di-C 0x0 azelate, di-n-heptyl isosebacate, di-C OX0 :adipate, \di-nonyl adipate, di-C 0x0 adipate, di-2- ethylhexyl adipate, mono C Oxo, mono C Oxo adipate, dl-Cq Oxo adipate, di-C trimethyl adipate, di-C Oxo pimelate, etc. Other operable diesters are those prepared from glycols and monocarboxylic acids such as dipropylene glycol dipelargonate and polyethylene glycol 200 dicaproate. Diesters prepared the 0x0 alcohols, which are isomeric mixtures of branched chain aliphatic primary alcohols, are particularly desirable. The Oxo alcohols have a very high degree of branching in the hydrocarbon chain, which results in diester oils having low pour points and low visoosities at low temperatures. These alcohols are prepared from olefins, such as polymers and copolymers of C and C monoolefins, which are reacted with carbon monoxide and hydrogen in the presence of a cobalt-containing catalyst such as a cobalt carbonyl, at temperatures of about 300 to 400 F., and under pressures of about 17000 to 3000 psi. to form aldehydes. The resulting aldehyde product is then bydrogenated to form the 0x0 alcohol which is then recovered by distillation from the hydrogenation product.
Operable polyesters are prepared by reacting polyhydric alcohols such as tn'methylolpropane and pentaerythritol with monocarboxylic acids such .as butyric acid, caproic acid, caprylic acid, pelargonic acid, etc. to give the corresponding trior tetraestens.
The complex esters which may be used as the base oils are formed by esterification reactions between a di carboxylic acid, a glycol, and an alcohol and/or a monocarboxylic acid. These esters may be represented by the following formulas:
wherein: R and R are alkyl radicals of a monohydric alcohol or a monocarboxylic acid; R and R are hydrogen radicals of dicarboxylic acids, e.g. alkandioic acids; and R and R are divalent hydrocarbon or hydro carbon-oxy radicals, such as -CH (CH or -CH CH (O CH CH or CH CH CH OCH CH (CH derived from an alkylene glycol or polyalkylene glycol. n in the complex ester molecule will usually range from 1 to 6 depending upon the product viscosity desired which is controlled by the relative molar ratio of the glycol or polyglycol to the dicarboxylic acid. In preparing the complex ester, there will always be some simple ester formed, i.e. n=0, but this will generally be a minor portion.
Some specific materials used in preparing the above types 'of complex esters are as follows: alcohols having 6 to 13 carbon atoms such as nbutyl alcohol, 2-ethylbutyl alcohol, 2-ethylhexano1, n-hexyl alcohol, C Oxo alcohol and C Oxo alcohol, etc.; the corresponding fatty or monocarboxylic acids; C to C dicarboxylic acids such as sebacic, adipic and azelaic; and glycols such as polyethylene glycol. In general the complex esters will have a total of 20 to 80, preferably 40 to 65, carbon atoms. These complex esters and methods for their preparation are known in the art and have been described in various patents.
The composition can also include other additives (e.g. 0.01 to 10.0 wt. percent). Included are oxidation inhibitors such as phenothiazine, dioctyl phenothiazine, dioctyl diphenylamine, phenyl u-naphthylamine, p-amino diphenyl amine; viscosity index improvers such as polymethacrylates, polystyrene; anti-foamant-s such as dimethylsilicone polymers; anti-wear agents such as tricresyl phosphate; load-carrying agents; etc.
Particularly, desirable load-carrying agents are various alkylene glycol titanates. These materials may be represented by the general formula:
where R is an aliphatic radical having from about 3 to 15, and preferably from 6 to 12, carbon atoms. It is, of course, possible for both hydroxyl groups of one glycol to react with two of the acidic groups of titanic acid molecules to form polymeric materials.
The more probable formulae for the glycol titanates are for the monoglycol or diglycol titanates, respectively, where R is the aliphatic radical of the glycol as heretofore stated.
Alkoxy glycol titanates are also contemplated, represented by the formula:
)6? a an D 0R 0 where R is the aliphatic radical of the glycol as heretofore stated and R is an aliphatic radical of from 3 to 12 carbon atoms, e.g. dibutoxy di(hexylene glycol) titanate.
Specific examples of the titanates include hexylene glycol titanate, dodecylene glycol titanate, octylene glycol titanate, and dibutoxy di(hexylene glycol) titanate. Titanates of the preceding types are known in the art and have been described in various patents, e.g. U. S. Patent No. 2,643,262.
The titanates are preferably used in amounts of 0.01 to 5.0 wt. percent as load-carrying agents. While extremely effective for carrying load, titanates are very corrosive to copper and lead. Although conventional lead and copper corrosion inhibitors were not effective with titanates, the anhydrides of the present invention are efiective.
The present invention will be further understood by reference to the following examples which include preferred embodiments of the present invention:
EXAMPLE I A base oil material was prepared consisting of 100 parts by weight of 50 volume percent of a di-C Oxo adipate and 50 volume wt. percent of di-C Oxo adipate, and 1 part by weight of phenothiazine as an antioxidant.
To the above base oil was added pyromellitic dianhydride, and/ or an alkylene glycol titanate in various amounts. The titanate was a solution of about 30 wt. percent n-butyl alcohol and about 70 wt. percent of tetra- (octylene glycol) titanate prepared by transesterification' of one molar amount of tetra n-butyl titanate with four molar amounts of Z-ethyl-hexane diol. This was a commercial product sold by DuPont under the tradename OGT-41. The resulting blends were then tested for lead corrosion inhibition in accordance with the MILFL- 7808 specification procedure. This test procedure is carried out by rapidly rotating a weighed bi-rnetallic strip, consisting of a lead strip and a copper strip bound together, in the oil sample maintained at 325 F. while air is bubbled through the sample. The weight loss of the strip is determined in terms of milligram weight loss per sq. inch of lead surface at the end of l, 4, 8 and 12 hours of operation. The compositions prepared and the results obtained are summarized in Table I, which follows:
Table I EFFECT OF PYROMELLITIO DIANHYDRIDE (PMDA) ON LEAD CORROSION Lead corrosion test loss in mgJin.
1 hour 4 hours 8 hours l2h0urs A. Base 0. 4 0. 6 0. 6 1. 8 B. A plus 0.05 weight percent PMDA 0 0 O 0 C. A plus 1 weight percent tetra- (octylene glycol) titanate 65 195 454 750 D. 0 plus 0.1 weight percent PMDA- 0 0 30 220 E. 0 plus 0.2 weight percent PMDA- 0 0 0 0 F. 0 plus 0.3 weight percent PMDA 0 0 1 1 G. CplusOAweightpercentPMDA 0.2 0.4 16 51 H. A plus 3 weight percent tetra- (octylene glycol) titanate 37 172 477 798 I. H plus 0.1 weight percent PMDA 25 124 447 788 J. H plus 0.2 weight percent PMDA- 0 4 36 441 K. H plus0.3 weight percent PMDA- 1 42 323 682 L. Hplus0.4weightpercentPMDAL 0 0 8 400 1 50 vol. plercent di-Cw Oxo adipate, 50 vol. percent (ii-C3 0x0 adlpate plus 1 weig t percent phenothiazine.
2 Some PMDA precipitated.
EXAMPLE II An ester oil mixture was prepared consisting of 50 volume percent di-C 0x0 adipate and 50 volume percent of di-C Oxo adipate. To this oil mixture was added 0.5 wt. percent phenothiazine as antioxidant, and 0.001 wt. percent of a diamethyl silicone having a viscosity of 60,000 cs. at 25 C. as an antifoamant. To this base oil composition was added 0.6 wt. percent of a C alkenyl succinic anhydride having the formula:
CHrO
The base oil composition per se and the base oil composition containing the succinic anhydride were tested in the lead corrosion test previously described above, and in an oxidation-corrosion test which determined the oxidative stability and the corrosivity of the compositions to copper, magnesium, iron, aluminum and silver. These tests were carried out in accordance with MlLL-7808C specification procedures. In the oxidation-corrosion test, weighed strips of the metals to be tested were immersed in cc. of the oil sample maintained at 347 F. for 72 hours while 0.5 liter per hour of air was bubbled through the sample. The metal strips were then reweighed to determine the corrosivity of the oil as indicated by the weight change in mg./cm. The oxidative stability of the oil was shown by the change in viscosity and neutralization number of the oil after testing.
The results of the above tests are summarized in Table II which follows:
Table II EFFECT OF Ca ALKENYL SUCOINIO ANHYDRIDE Adipate Adipate base base 1 plus 0.6%
anhydrlde Lead corrosion te t m [in 4 hrs. 21 0 8 hrs. 89 0 12 hrs 340 1. 2 347 F. oxidation corrosion test:
A neut. numbeL- 0. 87 0. 47
A vis./100% 3. 6 2.0
1 Adipate Base: 50 vol. percent C! 0x0 adipate plus 50 vol. percent 010 0x0 adipate plus 0.5 weight percent phenothiazine plus 0.001 weight percent -200 (60,000 cs.) silicone.
EXAMPLE III A base oil composition consisting predominantly of di-C /C OX0 adipate and di-octyl sebacate plus various lubricating oil additives Was prepared and stored for six months, during which time it had developed a high corrosivity toward lead. To samples of this highly corrosive base oil were then added phthalic anhydride and pyromellitic anhydride to determine their eifect on reduoing the lead corrosion of the base oil. From the results shown in the following table it will be noted that each anhydride inhibits the lead corrosivity of the base oil but that the pyromellitic dianhydride is more effective than the phthalic anhydride. This is also true when the corrosive oil is stored under high temperature conditions for 14 days.
Table III EFFECT OF PHIHALIC ANHYDRIDE AND PYROMELLITIC DIANHYDRIDE ON LEAD CORROSION It has been found that when the acid anhydride is to be used with an alkylene glycol titanate, excellent results are also obtained upon heating the titanate and anhydride to temperatures of about 275 to 325 F. for about 0.1 to 1.0 hour. It is believed that this heating results in the formation of a complex between the glycol titanate and the anhydride. Alternatively the two materials may be mixed cold, i.e. at room temperature in the ester oil relying upon the heating of the lubricating oil during use to help promote the reaction.
100 grams of the previously described tetra (octylene glycol) titanate prepared from 2-ethylhexane diol was dissolved in 100 grams of di(C Oxo) adipate and the solution heated to 300 F. to remove much of the diluent n-butyl alcohol introduced with the titanate. At this point 10 grams of pyromellitic dianhydride was added and stirred into the mixture. The mixture was then further heated for about 0.3 hour. Upon cooling, the resulting complex titanate solution Was then used in formultaing two lubricating oil blends as follows:
Blend A.The blend was prepared, wherein all parts are by weight, by simple mixing of 100 parts of di(2 ethylhexyl) sebacate, 1 part phenothiazine, 0.001 part of silicone anti-foamant and 0.7 part of the solution of complex of octylene glycol titanate and pyromellitic dianhydride. The composition carried 3,765 pound/inch load in the Ryder gear test and showed no corrosion in the lead corrosion test after 12 hours. On the other hand, the sebacate ester without the complex will carry only about 1,900 lb./in. in the Ryder gear test, while the addition to the titanate per se to the ester oil would result in severe lead corrosion.
Blend B.-To parts by Weight of a 50/50 volume mixttue of di(C Oxo) adipate and di(C 0x0) adipate was added 0.7 part by weight of phenothiazine and 0.7 part by weight of the solution of complex ti-tanate. This composition carried 3,440 1b./in. load in the Ryder gear test. It also showed only 5.0 mg./in. weight loss in the lead corrosion test at the end of 12 hours, which is within acceptable limits.
In sum, the present invention includes the addition to lubricating oils of monoand di-anhydrides of the formula: R(X) where R is a hydrocarbon radical, X is the anhydride group and n is one or two. R can also include a carboxylic acid group substituted on the hydrocarbon chain. The total number of carbon atoms in the molecule will be 8 to 50, e.g. 8 to 30. As a further aspect of the invention, heating the anhydride with alkylene glycol titanates, either mono-, di-, tri-, or tetratitanates or mixtures thereof results in some sort of a complex which is particularly useful as a load-carrying agent with low corrosivity to lead.
What is claimed is:
1. A synthetic ester lubricating oil composition comprising a major proportion of carboxylic acid ester lubricating oil and about 0.001 to 5.0 wt. percent of pyromellitic dianhydride.
2. A synthetic ester lubricating oil composition according to claim 1, which also contains about 0.01 to 5 .0 wt. percent of an alkylene glycol titanate prepared from C to C aliphatic glycol.
3. A lubricating oil composition comprising a major proportion of diester of the formula:
ROOCRCOOR wherein R represents a C to C alkyl radical and R is a C to C aliphatic hydrocarbon radical, and about 0.001
to 5.0 wt. percent based upon the total composition, of pyromellitic dianhydride.
References Cited in the file of this patent UNITED STATES PATENTS 2,334,158 Von Fuchs, et a1. Nov. 9, 1943 2,788,326 Bondi et al. Apr. 9, 1957 2,806,860 Phillips et al. Sept. 17, 1957 2,809,160 Stewart et a1 Oct. 8, 1957 2,960,469 Young et al Nov. 15, 1960 FOREIGN PATENTS 809,198 Great Britain Feb. =18, 1959

Claims (1)

1. A SYNTHETIC ESTER LUBRICATING OIL COMPOSITION COMPRISING A MAJOR PROPORTION OF CARBOXYLIC ACID ESTER LUBRICATING OIL AND ABOUT 0.001 TO 5.0 WT. PERCENT OF PYROMETALLITIC DIANHYDRIDE.
US46878A 1960-08-02 1960-08-02 Ester oil compositions containing acid anhydride Expired - Lifetime US3090753A (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
US46878A US3090753A (en) 1960-08-02 1960-08-02 Ester oil compositions containing acid anhydride
GB22428/61A GB947609A (en) 1960-08-02 1961-06-21 Ester oil compositions containing acid anhydride

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US46878A US3090753A (en) 1960-08-02 1960-08-02 Ester oil compositions containing acid anhydride

Publications (1)

Publication Number Publication Date
US3090753A true US3090753A (en) 1963-05-21

Family

ID=21945889

Family Applications (1)

Application Number Title Priority Date Filing Date
US46878A Expired - Lifetime US3090753A (en) 1960-08-02 1960-08-02 Ester oil compositions containing acid anhydride

Country Status (2)

Country Link
US (1) US3090753A (en)
GB (1) GB947609A (en)

Cited By (96)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3261780A (en) * 1963-10-31 1966-07-19 Standard Oil Co Lubricant additive and lubricating compositions
US3261781A (en) * 1963-11-15 1966-07-19 Standard Oil Co Lubricant additive and lubricating compositions
US3290248A (en) * 1963-03-05 1966-12-06 British Petroleum Co Siloxane ester lubricants
US3328302A (en) * 1962-05-24 1967-06-27 Geigy Co Ltd Synthetic lubricants comprising organic esters
US3368975A (en) * 1966-06-02 1968-02-13 Eastman Kodak Co Antioxidants
US4209411A (en) * 1979-03-23 1980-06-24 Exxon Research & Engineering Co. Methylol polyesters of C12 -C22 hydrocarbon substituted succinic anhydride or acid, their preparation and use as additives for lubricants and fuels
US4422953A (en) * 1982-04-21 1983-12-27 Petrolite Corporation Corrosion inhibition of halocarbon systems
WO2003031059A2 (en) * 2001-10-09 2003-04-17 Cyclics Corporation Organo-titanate catalysts for preparing pure macrocyclic oligoesters
US20030162654A1 (en) * 2002-01-07 2003-08-28 Yi-Feng Wang Polymer-containing organo-metal catalysts
US20030195328A1 (en) * 2002-03-20 2003-10-16 Yi-Feng Wang Catalytic systems
US20030236386A1 (en) * 2000-09-01 2003-12-25 Faler Gary R. Methods for converting linear polyesters to macrocyclic oligoester compositions and macrocyclic oligoesters
US20040011992A1 (en) * 2000-01-21 2004-01-22 Cyclics Corporation Macrocyclic polyester oligomers and processes for polymerizing the same
US20040192879A1 (en) * 2002-12-20 2004-09-30 Phelps Peter D. Purification of macrocyclic oligoesters
US20040220334A1 (en) * 2000-01-21 2004-11-04 Yi-Feng Wang Blends containing macrocyclic polyester oligomer and high molecular weight polymer
US20040225058A1 (en) * 2000-01-21 2004-11-11 Tohru Takekoshi Intimate physical mixtures containing macrocyclic polyester oligomer and filler
US20040254281A1 (en) * 2001-06-27 2004-12-16 Thompson Timothy A Isolation, formulation and shaping of macrocyclic oligoesters
US20050137333A1 (en) * 2003-12-19 2005-06-23 Cyclics Corporation Processes for dispersing an impact modifier in a macrocyclic polyester oligomer
US20050282952A1 (en) * 2000-01-21 2005-12-22 Cyclics Corporation Graphite-polyester composites made from macrocyclic polyester oligomers
US20060039004A1 (en) * 2004-08-06 2006-02-23 The General Hospital Corporation Process, system and software arrangement for determining at least one location in a sample using an optical coherence tomography
US20060115666A1 (en) * 2000-01-21 2006-06-01 Cyclics Corporation Methods for polymerizing macrocyclic polyester oligomers using catalyst promoters
US20060194946A1 (en) * 2001-06-27 2006-08-31 Cyclics Corporation Processes for shaping macrocyclic oligoesters
US20060227333A1 (en) * 2003-03-31 2006-10-12 Tearney Guillermo J Speckle reduction in optical coherence tomography by path length encoded angular compounding
US20060235185A1 (en) * 2000-09-01 2006-10-19 Cyclics Corporation Preparation of low-acid polyalkylene terephthalate and preparation of macrocyclic polyester oligomer therefrom
US20070081236A1 (en) * 2005-09-29 2007-04-12 The General Hospital Corporation Method and apparatus for optical imaging via spectral encoding
US20070177152A1 (en) * 2006-02-01 2007-08-02 The General Hospital Corporation Methods and systems for monitoring and obtaining information of at least one portion of a sample using conformal laser therapy procedures, and providing electromagnetic radiation thereto
US20070238955A1 (en) * 2006-01-18 2007-10-11 The General Hospital Corporation Systems and methods for generating data using one or more endoscopic microscopy techniques
US20070263208A1 (en) * 2006-01-10 2007-11-15 The General Hospital Corporation Systems and methods for generating data based on one or more spectrally-encoded endoscopy techniques
US20080100837A1 (en) * 2002-01-24 2008-05-01 The General Hospital Corporation Apparatus and method for ranging and noise reduction of low coherence interferometry lci and optical coherence tomography oct signals by parallel detection of spectral bands
US20090022463A1 (en) * 2004-07-02 2009-01-22 The General Hospital Corporation Imaging system and related techniques
US20090027689A1 (en) * 2003-10-27 2009-01-29 The General Hospital Corporation Method and apparatus for performing optical imaging using frequency-domain interferometry
US20090043192A1 (en) * 2001-05-01 2009-02-12 The General Hospital Corporation Method and apparatus for determination of atherosclerotic plaque type by measurement of tissue optical properties
US7519096B2 (en) 2003-06-06 2009-04-14 The General Hospital Corporation Process and apparatus for a wavelength tuning source
US20090196477A1 (en) * 2004-05-29 2009-08-06 The General Hospital Corporation Process, System And Software Arrangement For A Chromatic Dispersion Compensation Using Reflective Layers In Optical Coherence Tomography (OCT) Imaging
US20090273777A1 (en) * 2008-04-30 2009-11-05 The General Hospital Corporation Apparatus and method for cross axis parallel spectroscopy
US20090323056A1 (en) * 2007-05-04 2009-12-31 The General Hospital Corporation Methods, arrangements and systems for obtaining information associated with a sample using optical microscopy
US20100150422A1 (en) * 2008-12-10 2010-06-17 The General Hospital Corporation Systems and Methods for Extending Imaging Depth Range of Optical Coherence Tomography Through Optical Sub-Sampling
US7742173B2 (en) 2006-04-05 2010-06-22 The General Hospital Corporation Methods, arrangements and systems for polarization-sensitive optical frequency domain imaging of a sample
US7750109B2 (en) 2000-09-01 2010-07-06 Cyclics Corporation Use of a residual oligomer recyclate in the production of macrocyclic polyester oligomer
US7782464B2 (en) 2006-05-12 2010-08-24 The General Hospital Corporation Processes, arrangements and systems for providing a fiber layer thickness map based on optical coherence tomography images
US7889348B2 (en) 2005-10-14 2011-02-15 The General Hospital Corporation Arrangements and methods for facilitating photoluminescence imaging
US7920271B2 (en) 2006-08-25 2011-04-05 The General Hospital Corporation Apparatus and methods for enhancing optical coherence tomography imaging using volumetric filtering techniques
US7933021B2 (en) 2007-10-30 2011-04-26 The General Hospital Corporation System and method for cladding mode detection
US7949019B2 (en) 2007-01-19 2011-05-24 The General Hospital Wavelength tuning source based on a rotatable reflector
US7982879B2 (en) 2006-02-24 2011-07-19 The General Hospital Corporation Methods and systems for performing angle-resolved fourier-domain optical coherence tomography
US7995210B2 (en) 2004-11-24 2011-08-09 The General Hospital Corporation Devices and arrangements for performing coherence range imaging using a common path interferometer
US8040608B2 (en) 2007-08-31 2011-10-18 The General Hospital Corporation System and method for self-interference fluorescence microscopy, and computer-accessible medium associated therewith
US8045177B2 (en) 2007-04-17 2011-10-25 The General Hospital Corporation Apparatus and methods for measuring vibrations using spectrally-encoded endoscopy
US8054468B2 (en) 2003-01-24 2011-11-08 The General Hospital Corporation Apparatus and method for ranging and noise reduction of low coherence interferometry LCI and optical coherence tomography OCT signals by parallel detection of spectral bands
US8097864B2 (en) 2009-01-26 2012-01-17 The General Hospital Corporation System, method and computer-accessible medium for providing wide-field superresolution microscopy
US8145018B2 (en) 2006-01-19 2012-03-27 The General Hospital Corporation Apparatus for obtaining information for a structure using spectrally-encoded endoscopy techniques and methods for producing one or more optical arrangements
US8175685B2 (en) 2006-05-10 2012-05-08 The General Hospital Corporation Process, arrangements and systems for providing frequency domain imaging of a sample
US8208995B2 (en) 2004-08-24 2012-06-26 The General Hospital Corporation Method and apparatus for imaging of vessel segments
USRE43875E1 (en) 2004-09-29 2012-12-25 The General Hospital Corporation System and method for optical coherence imaging
US8351665B2 (en) 2005-04-28 2013-01-08 The General Hospital Corporation Systems, processes and software arrangements for evaluating information associated with an anatomical structure by an optical coherence ranging technique
USRE44042E1 (en) 2004-09-10 2013-03-05 The General Hospital Corporation System and method for optical coherence imaging
US8593619B2 (en) 2008-05-07 2013-11-26 The General Hospital Corporation System, method and computer-accessible medium for tracking vessel motion during three-dimensional coronary artery microscopy
US8804126B2 (en) 2010-03-05 2014-08-12 The General Hospital Corporation Systems, methods and computer-accessible medium which provide microscopic images of at least one anatomical structure at a particular resolution
US8838213B2 (en) 2006-10-19 2014-09-16 The General Hospital Corporation Apparatus and method for obtaining and providing imaging information associated with at least one portion of a sample, and effecting such portion(s)
US8861910B2 (en) 2008-06-20 2014-10-14 The General Hospital Corporation Fused fiber optic coupler arrangement and method for use thereof
US8922781B2 (en) 2004-11-29 2014-12-30 The General Hospital Corporation Arrangements, devices, endoscopes, catheters and methods for performing optical imaging by simultaneously illuminating and detecting multiple points on a sample
US8965487B2 (en) 2004-08-24 2015-02-24 The General Hospital Corporation Process, system and software arrangement for measuring a mechanical strain and elastic properties of a sample
US9060689B2 (en) 2005-06-01 2015-06-23 The General Hospital Corporation Apparatus, method and system for performing phase-resolved optical frequency domain imaging
US9069130B2 (en) 2010-05-03 2015-06-30 The General Hospital Corporation Apparatus, method and system for generating optical radiation from biological gain media
US9087368B2 (en) 2006-01-19 2015-07-21 The General Hospital Corporation Methods and systems for optical imaging or epithelial luminal organs by beam scanning thereof
US9176319B2 (en) 2007-03-23 2015-11-03 The General Hospital Corporation Methods, arrangements and apparatus for utilizing a wavelength-swept laser using angular scanning and dispersion procedures
US9254089B2 (en) 2008-07-14 2016-02-09 The General Hospital Corporation Apparatus and methods for facilitating at least partial overlap of dispersed ration on at least one sample
US9282931B2 (en) 2000-10-30 2016-03-15 The General Hospital Corporation Methods for tissue analysis
US9295391B1 (en) 2000-11-10 2016-03-29 The General Hospital Corporation Spectrally encoded miniature endoscopic imaging probe
US9330092B2 (en) 2011-07-19 2016-05-03 The General Hospital Corporation Systems, methods, apparatus and computer-accessible-medium for providing polarization-mode dispersion compensation in optical coherence tomography
US9341783B2 (en) 2011-10-18 2016-05-17 The General Hospital Corporation Apparatus and methods for producing and/or providing recirculating optical delay(s)
US9351642B2 (en) 2009-03-12 2016-05-31 The General Hospital Corporation Non-contact optical system, computer-accessible medium and method for measurement at least one mechanical property of tissue using coherent speckle technique(s)
US9375158B2 (en) 2007-07-31 2016-06-28 The General Hospital Corporation Systems and methods for providing beam scan patterns for high speed doppler optical frequency domain imaging
US9441948B2 (en) 2005-08-09 2016-09-13 The General Hospital Corporation Apparatus, methods and storage medium for performing polarization-based quadrature demodulation in optical coherence tomography
US9510758B2 (en) 2010-10-27 2016-12-06 The General Hospital Corporation Apparatus, systems and methods for measuring blood pressure within at least one vessel
US9557154B2 (en) 2010-05-25 2017-01-31 The General Hospital Corporation Systems, devices, methods, apparatus and computer-accessible media for providing optical imaging of structures and compositions
US9615748B2 (en) 2009-01-20 2017-04-11 The General Hospital Corporation Endoscopic biopsy apparatus, system and method
US9629528B2 (en) 2012-03-30 2017-04-25 The General Hospital Corporation Imaging system, method and distal attachment for multidirectional field of view endoscopy
US9668652B2 (en) 2013-07-26 2017-06-06 The General Hospital Corporation System, apparatus and method for utilizing optical dispersion for fourier-domain optical coherence tomography
US9733460B2 (en) 2014-01-08 2017-08-15 The General Hospital Corporation Method and apparatus for microscopic imaging
US9777053B2 (en) 2006-02-08 2017-10-03 The General Hospital Corporation Methods, arrangements and systems for obtaining information associated with an anatomical sample using optical microscopy
US9784681B2 (en) 2013-05-13 2017-10-10 The General Hospital Corporation System and method for efficient detection of the phase and amplitude of a periodic modulation associated with self-interfering fluorescence
US9795301B2 (en) 2010-05-25 2017-10-24 The General Hospital Corporation Apparatus, systems, methods and computer-accessible medium for spectral analysis of optical coherence tomography images
US9968261B2 (en) 2013-01-28 2018-05-15 The General Hospital Corporation Apparatus and method for providing diffuse spectroscopy co-registered with optical frequency domain imaging
US10117576B2 (en) 2013-07-19 2018-11-06 The General Hospital Corporation System, method and computer accessible medium for determining eye motion by imaging retina and providing feedback for acquisition of signals from the retina
US10228556B2 (en) 2014-04-04 2019-03-12 The General Hospital Corporation Apparatus and method for controlling propagation and/or transmission of electromagnetic radiation in flexible waveguide(s)
US10241028B2 (en) 2011-08-25 2019-03-26 The General Hospital Corporation Methods, systems, arrangements and computer-accessible medium for providing micro-optical coherence tomography procedures
US10285568B2 (en) 2010-06-03 2019-05-14 The General Hospital Corporation Apparatus and method for devices for imaging structures in or at one or more luminal organs
US10426548B2 (en) 2006-02-01 2019-10-01 The General Hosppital Corporation Methods and systems for providing electromagnetic radiation to at least one portion of a sample using conformal laser therapy procedures
US10534129B2 (en) 2007-03-30 2020-01-14 The General Hospital Corporation System and method providing intracoronary laser speckle imaging for the detection of vulnerable plaque
US10736494B2 (en) 2014-01-31 2020-08-11 The General Hospital Corporation System and method for facilitating manual and/or automatic volumetric imaging with real-time tension or force feedback using a tethered imaging device
US10893806B2 (en) 2013-01-29 2021-01-19 The General Hospital Corporation Apparatus, systems and methods for providing information regarding the aortic valve
US10912462B2 (en) 2014-07-25 2021-02-09 The General Hospital Corporation Apparatus, devices and methods for in vivo imaging and diagnosis
US11179028B2 (en) 2013-02-01 2021-11-23 The General Hospital Corporation Objective lens arrangement for confocal endomicroscopy
US11452433B2 (en) 2013-07-19 2022-09-27 The General Hospital Corporation Imaging apparatus and method which utilizes multidirectional field of view endoscopy
US11490797B2 (en) 2012-05-21 2022-11-08 The General Hospital Corporation Apparatus, device and method for capsule microscopy
US11490826B2 (en) 2009-07-14 2022-11-08 The General Hospital Corporation Apparatus, systems and methods for measuring flow and pressure within a vessel

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9613756D0 (en) * 1996-07-01 1996-09-04 Bingley Michael S Additive composition

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2334158A (en) * 1941-09-29 1943-11-09 Shell Dev Rust-preventive composition
US2788326A (en) * 1950-12-26 1957-04-09 Shell Dev Extreme pressure lubricant
US2806860A (en) * 1955-07-20 1957-09-17 Union Carbide Corp Epoxyalkyl succinic anhydrides
US2809160A (en) * 1955-12-29 1957-10-08 California Research Corp Lubricant composition
GB809198A (en) * 1954-12-29 1959-02-18 California Research Corp Lubricant composition
US2960469A (en) * 1956-04-19 1960-11-15 Sinclair Refining Co Load carrying lubricant

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2334158A (en) * 1941-09-29 1943-11-09 Shell Dev Rust-preventive composition
US2788326A (en) * 1950-12-26 1957-04-09 Shell Dev Extreme pressure lubricant
GB809198A (en) * 1954-12-29 1959-02-18 California Research Corp Lubricant composition
US2806860A (en) * 1955-07-20 1957-09-17 Union Carbide Corp Epoxyalkyl succinic anhydrides
US2809160A (en) * 1955-12-29 1957-10-08 California Research Corp Lubricant composition
US2960469A (en) * 1956-04-19 1960-11-15 Sinclair Refining Co Load carrying lubricant

Cited By (194)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3328302A (en) * 1962-05-24 1967-06-27 Geigy Co Ltd Synthetic lubricants comprising organic esters
US3290248A (en) * 1963-03-05 1966-12-06 British Petroleum Co Siloxane ester lubricants
US3261780A (en) * 1963-10-31 1966-07-19 Standard Oil Co Lubricant additive and lubricating compositions
US3261781A (en) * 1963-11-15 1966-07-19 Standard Oil Co Lubricant additive and lubricating compositions
US3368975A (en) * 1966-06-02 1968-02-13 Eastman Kodak Co Antioxidants
US4209411A (en) * 1979-03-23 1980-06-24 Exxon Research & Engineering Co. Methylol polyesters of C12 -C22 hydrocarbon substituted succinic anhydride or acid, their preparation and use as additives for lubricants and fuels
US4422953A (en) * 1982-04-21 1983-12-27 Petrolite Corporation Corrosion inhibition of halocarbon systems
US20060115666A1 (en) * 2000-01-21 2006-06-01 Cyclics Corporation Methods for polymerizing macrocyclic polyester oligomers using catalyst promoters
US20060122307A1 (en) * 2000-01-21 2006-06-08 Cyclics Corporation Intimate physical mixtures containing macrocyclic polyester oligomer and filler
US6994914B2 (en) 2000-01-21 2006-02-07 Cyclics Corporation Macrocyclic polyester oligomers and processes for polymerizing the same
US20050282952A1 (en) * 2000-01-21 2005-12-22 Cyclics Corporation Graphite-polyester composites made from macrocyclic polyester oligomers
US7151143B2 (en) 2000-01-21 2006-12-19 Cyclics Corporation Blends containing macrocyclic polyester oligomer and high molecular weight polymer
US20050245676A1 (en) * 2000-01-21 2005-11-03 Cyclics Corporation Macrocyclic polyester oligomers and processes for polymerizing the same
US20040011992A1 (en) * 2000-01-21 2004-01-22 Cyclics Corporation Macrocyclic polyester oligomers and processes for polymerizing the same
US6960626B2 (en) 2000-01-21 2005-11-01 Cyclics Corporation Intimate physical mixtures containing macrocyclic polyester oligomer and filler
US7230044B2 (en) 2000-01-21 2007-06-12 Cyclics Corporation Intimate physical mixtures containing macrocyclic polyester oligomer and filler
US20040220334A1 (en) * 2000-01-21 2004-11-04 Yi-Feng Wang Blends containing macrocyclic polyester oligomer and high molecular weight polymer
US20040225058A1 (en) * 2000-01-21 2004-11-11 Tohru Takekoshi Intimate physical mixtures containing macrocyclic polyester oligomer and filler
US7256241B2 (en) 2000-01-21 2007-08-14 Cyclics Corporation Methods for polymerizing macrocyclic polyester oligomers using catalyst promoters
US20050176917A1 (en) * 2000-09-01 2005-08-11 Cyclics Corporation Methods for converting linear polyesters to macrocyclic oligoester compositions and macrocyclic oligoesters
US8283437B2 (en) 2000-09-01 2012-10-09 Cyclics Corporation Preparation of low-acid polyalkylene terephthalate and preparation of macrocyclic polyester oligomer therefrom
US7309756B2 (en) 2000-09-01 2007-12-18 Cyclics Corporation Methods for converting linear polyesters to macrocyclic oligoester compositions and macrocyclic oligoesters
US7022806B2 (en) 2000-09-01 2006-04-04 Cyclics Corporation Methods for converting linear polyesters to macrocyclic oligoester compositions and macrocyclic oligoesters
US20080214775A1 (en) * 2000-09-01 2008-09-04 Cyclics Corporation Methods for converting linear polyesters to macrocyclic oligoester compositions and macrocyclic oligoesters
US20060128936A1 (en) * 2000-09-01 2006-06-15 Cyclics Corporation Methods for converting linear polyesters to macrocyclic oligoester compositions and macrocyclic oligoesters
US20060235185A1 (en) * 2000-09-01 2006-10-19 Cyclics Corporation Preparation of low-acid polyalkylene terephthalate and preparation of macrocyclic polyester oligomer therefrom
US6855798B2 (en) 2000-09-01 2005-02-15 Cyclics Corporation Methods for converting linear polyesters to macrocyclic oligoester compositions and macrocyclic oligoesters
US20030236386A1 (en) * 2000-09-01 2003-12-25 Faler Gary R. Methods for converting linear polyesters to macrocyclic oligoester compositions and macrocyclic oligoesters
US7767781B2 (en) 2000-09-01 2010-08-03 Cyclics Corporation Preparation of low-acid polyalkylene terephthalate and preparation of macrocyclic polyester oligomer therefrom
US7750109B2 (en) 2000-09-01 2010-07-06 Cyclics Corporation Use of a residual oligomer recyclate in the production of macrocyclic polyester oligomer
US9282931B2 (en) 2000-10-30 2016-03-15 The General Hospital Corporation Methods for tissue analysis
US9295391B1 (en) 2000-11-10 2016-03-29 The General Hospital Corporation Spectrally encoded miniature endoscopic imaging probe
US8150496B2 (en) 2001-05-01 2012-04-03 The General Hospital Corporation Method and apparatus for determination of atherosclerotic plaque type by measurement of tissue optical properties
US20090043192A1 (en) * 2001-05-01 2009-02-12 The General Hospital Corporation Method and apparatus for determination of atherosclerotic plaque type by measurement of tissue optical properties
US8050747B2 (en) 2001-05-01 2011-11-01 The General Hospital Corporation Method and apparatus for determination of atherosclerotic plaque type by measurement of tissue optical properties
US20040254281A1 (en) * 2001-06-27 2004-12-16 Thompson Timothy A Isolation, formulation and shaping of macrocyclic oligoesters
US7071291B2 (en) 2001-06-27 2006-07-04 Cyclics Corporation Isolation, formulation and shaping of macrocyclic oligoesters
US20060194946A1 (en) * 2001-06-27 2006-08-31 Cyclics Corporation Processes for shaping macrocyclic oligoesters
US7666517B2 (en) 2001-06-27 2010-02-23 Cyclics Corporation Isolation, formulation, and shaping of macrocyclic oligoesters
US20070037464A1 (en) * 2001-06-27 2007-02-15 Cyclics Corporation Isolation, formulation, and shaping of macrocyclic oligoesters
US7304123B2 (en) 2001-06-27 2007-12-04 Cyclics Corporation Processes for shaping macrocyclic oligoesters
WO2003031059A3 (en) * 2001-10-09 2003-11-20 Cyclics Corp Organo-titanate catalysts for preparing pure macrocyclic oligoesters
US20030114640A1 (en) * 2001-10-09 2003-06-19 Phelps Peter D. Organo-titanate catalysts for preparing pure macrocyclic oligoesters
US6787632B2 (en) 2001-10-09 2004-09-07 Cyclics Corporation Organo-titanate catalysts for preparing pure macrocyclic oligoesters
US7615511B2 (en) 2001-10-09 2009-11-10 Cyclics Corporation Organo-titanate catalysts for preparing pure macrocyclic oligoesters
US20050054862A1 (en) * 2001-10-09 2005-03-10 Cyclics Corporation Organo-titanate catalysts for preparing pure macrocyclic oligoesters
WO2003031059A2 (en) * 2001-10-09 2003-04-17 Cyclics Corporation Organo-titanate catalysts for preparing pure macrocyclic oligoesters
US6831138B2 (en) 2002-01-07 2004-12-14 Cyclics Corporation Polymer-containing organo-metal catalysts
US20030162654A1 (en) * 2002-01-07 2003-08-28 Yi-Feng Wang Polymer-containing organo-metal catalysts
US7643152B2 (en) 2002-01-24 2010-01-05 The General Hospital Corporation Apparatus and method for ranging and noise reduction of low coherence interferometry LCI and optical coherence tomography OCT signals by parallel detection of spectral bands
US7630083B2 (en) 2002-01-24 2009-12-08 The General Hospital Corporation Apparatus and method for ranging and noise reduction of low coherence interferometry LCI and optical coherence tomography OCT signals by parallel detection of spectral bands
US7872757B2 (en) 2002-01-24 2011-01-18 The General Hospital Corporation Apparatus and method for ranging and noise reduction of low coherence interferometry LCI and optical coherence tomography OCT signals by parallel detection of spectral bands
US20080100837A1 (en) * 2002-01-24 2008-05-01 The General Hospital Corporation Apparatus and method for ranging and noise reduction of low coherence interferometry lci and optical coherence tomography oct signals by parallel detection of spectral bands
US20030195328A1 (en) * 2002-03-20 2003-10-16 Yi-Feng Wang Catalytic systems
US6906147B2 (en) 2002-03-20 2005-06-14 Cyclics Corporation Catalytic systems
US7186666B2 (en) 2002-03-20 2007-03-06 Cyclics Corporation Catalytic systems
US20050227861A1 (en) * 2002-03-20 2005-10-13 Cyclics Corporation Catalytic systems
US20040192879A1 (en) * 2002-12-20 2004-09-30 Phelps Peter D. Purification of macrocyclic oligoesters
US6962968B2 (en) 2002-12-20 2005-11-08 Cyclics Corporation Purification of macrocyclic oligoesters
US8174702B2 (en) 2003-01-24 2012-05-08 The General Hospital Corporation Speckle reduction in optical coherence tomography by path length encoded angular compounding
US8054468B2 (en) 2003-01-24 2011-11-08 The General Hospital Corporation Apparatus and method for ranging and noise reduction of low coherence interferometry LCI and optical coherence tomography OCT signals by parallel detection of spectral bands
US8559012B2 (en) 2003-01-24 2013-10-15 The General Hospital Corporation Speckle reduction in optical coherence tomography by path length encoded angular compounding
US9226665B2 (en) 2003-01-24 2016-01-05 The General Hospital Corporation Speckle reduction in optical coherence tomography by path length encoded angular compounding
US7567349B2 (en) 2003-03-31 2009-07-28 The General Hospital Corporation Speckle reduction in optical coherence tomography by path length encoded angular compounding
US20060227333A1 (en) * 2003-03-31 2006-10-12 Tearney Guillermo J Speckle reduction in optical coherence tomography by path length encoded angular compounding
US7519096B2 (en) 2003-06-06 2009-04-14 The General Hospital Corporation Process and apparatus for a wavelength tuning source
US7995627B2 (en) 2003-06-06 2011-08-09 The General Hospital Corporation Process and apparatus for a wavelength tuning source
USRE47675E1 (en) 2003-06-06 2019-10-29 The General Hospital Corporation Process and apparatus for a wavelength tuning source
US7724786B2 (en) 2003-06-06 2010-05-25 The General Hospital Corporation Process and apparatus for a wavelength tuning source
US8416818B2 (en) 2003-06-06 2013-04-09 The General Hospital Corporation Process and apparatus for a wavelength tuning source
US20100254414A1 (en) * 2003-06-06 2010-10-07 The General Hospital Corporation Process and apparatus for a wavelength tuning source
US9812846B2 (en) 2003-10-27 2017-11-07 The General Hospital Corporation Method and apparatus for performing optical imaging using frequency-domain interferometry
US9377290B2 (en) 2003-10-27 2016-06-28 The General Hospital Corporation Method and apparatus for performing optical imaging using frequency-domain interferometry
US7733497B2 (en) 2003-10-27 2010-06-08 The General Hospital Corporation Method and apparatus for performing optical imaging using frequency-domain interferometry
US8355138B2 (en) 2003-10-27 2013-01-15 The General Hospital Corporation Method and apparatus for performing optical imaging using frequency-domain interferometry
US8705046B2 (en) 2003-10-27 2014-04-22 The General Hospital Corporation Method and apparatus for performing optical imaging using frequency-domain interferometry
US20090027689A1 (en) * 2003-10-27 2009-01-29 The General Hospital Corporation Method and apparatus for performing optical imaging using frequency-domain interferometry
US8384909B2 (en) 2003-10-27 2013-02-26 The General Hospital Corporation Method and apparatus for performing optical imaging using frequency-domain interferometry
US7969578B2 (en) 2003-10-27 2011-06-28 The General Hospital Corporation Method and apparatus for performing optical imaging using frequency-domain interferometry
US20050137333A1 (en) * 2003-12-19 2005-06-23 Cyclics Corporation Processes for dispersing an impact modifier in a macrocyclic polyester oligomer
US20090196477A1 (en) * 2004-05-29 2009-08-06 The General Hospital Corporation Process, System And Software Arrangement For A Chromatic Dispersion Compensation Using Reflective Layers In Optical Coherence Tomography (OCT) Imaging
US8018598B2 (en) 2004-05-29 2011-09-13 The General Hospital Corporation Process, system and software arrangement for a chromatic dispersion compensation using reflective layers in optical coherence tomography (OCT) imaging
US7809225B2 (en) 2004-07-02 2010-10-05 The General Hospital Corporation Imaging system and related techniques
US8676013B2 (en) 2004-07-02 2014-03-18 The General Hospital Corporation Imaging system using and related techniques
US7925133B2 (en) 2004-07-02 2011-04-12 The General Hospital Corporation Imaging system and related techniques
US20090022463A1 (en) * 2004-07-02 2009-01-22 The General Hospital Corporation Imaging system and related techniques
US8369669B2 (en) 2004-07-02 2013-02-05 The General Hospital Corporation Imaging system and related techniques
US9664615B2 (en) 2004-07-02 2017-05-30 The General Hospital Corporation Imaging system and related techniques
US20060039004A1 (en) * 2004-08-06 2006-02-23 The General Hospital Corporation Process, system and software arrangement for determining at least one location in a sample using an optical coherence tomography
US9226660B2 (en) 2004-08-06 2016-01-05 The General Hospital Corporation Process, system and software arrangement for determining at least one location in a sample using an optical coherence tomography
US8081316B2 (en) 2004-08-06 2011-12-20 The General Hospital Corporation Process, system and software arrangement for determining at least one location in a sample using an optical coherence tomography
US9763623B2 (en) 2004-08-24 2017-09-19 The General Hospital Corporation Method and apparatus for imaging of vessel segments
US8208995B2 (en) 2004-08-24 2012-06-26 The General Hospital Corporation Method and apparatus for imaging of vessel segments
US9254102B2 (en) 2004-08-24 2016-02-09 The General Hospital Corporation Method and apparatus for imaging of vessel segments
US8965487B2 (en) 2004-08-24 2015-02-24 The General Hospital Corporation Process, system and software arrangement for measuring a mechanical strain and elastic properties of a sample
USRE44042E1 (en) 2004-09-10 2013-03-05 The General Hospital Corporation System and method for optical coherence imaging
USRE43875E1 (en) 2004-09-29 2012-12-25 The General Hospital Corporation System and method for optical coherence imaging
USRE45512E1 (en) 2004-09-29 2015-05-12 The General Hospital Corporation System and method for optical coherence imaging
US7995210B2 (en) 2004-11-24 2011-08-09 The General Hospital Corporation Devices and arrangements for performing coherence range imaging using a common path interferometer
US8922781B2 (en) 2004-11-29 2014-12-30 The General Hospital Corporation Arrangements, devices, endoscopes, catheters and methods for performing optical imaging by simultaneously illuminating and detecting multiple points on a sample
US9326682B2 (en) 2005-04-28 2016-05-03 The General Hospital Corporation Systems, processes and software arrangements for evaluating information associated with an anatomical structure by an optical coherence ranging technique
US8351665B2 (en) 2005-04-28 2013-01-08 The General Hospital Corporation Systems, processes and software arrangements for evaluating information associated with an anatomical structure by an optical coherence ranging technique
US9060689B2 (en) 2005-06-01 2015-06-23 The General Hospital Corporation Apparatus, method and system for performing phase-resolved optical frequency domain imaging
US9441948B2 (en) 2005-08-09 2016-09-13 The General Hospital Corporation Apparatus, methods and storage medium for performing polarization-based quadrature demodulation in optical coherence tomography
US8928889B2 (en) 2005-09-29 2015-01-06 The General Hospital Corporation Arrangements and methods for providing multimodality microscopic imaging of one or more biological structures
US8289522B2 (en) 2005-09-29 2012-10-16 The General Hospital Corporation Arrangements and methods for providing multimodality microscopic imaging of one or more biological structures
US7847949B2 (en) 2005-09-29 2010-12-07 The General Hospital Corporation Method and apparatus for optical imaging via spectral encoding
US9513276B2 (en) 2005-09-29 2016-12-06 The General Hospital Corporation Method and apparatus for optical imaging via spectral encoding
US20110058178A1 (en) * 2005-09-29 2011-03-10 The General Hospital Corporation Arrangements and methods for providing multimodality microscopic imaging of one or more biological structures
US7872759B2 (en) 2005-09-29 2011-01-18 The General Hospital Corporation Arrangements and methods for providing multimodality microscopic imaging of one or more biological structures
US8149418B2 (en) 2005-09-29 2012-04-03 The General Hospital Corporation Method and apparatus for optical imaging via spectral encoding
US8384907B2 (en) 2005-09-29 2013-02-26 The General Hospital Corporation Method and apparatus for optical imaging via spectral encoding
US7843572B2 (en) 2005-09-29 2010-11-30 The General Hospital Corporation Method and apparatus for optical imaging via spectral encoding
US20070081236A1 (en) * 2005-09-29 2007-04-12 The General Hospital Corporation Method and apparatus for optical imaging via spectral encoding
US8760663B2 (en) 2005-09-29 2014-06-24 The General Hospital Corporation Method and apparatus for optical imaging via spectral encoding
US9304121B2 (en) 2005-09-29 2016-04-05 The General Hospital Corporation Method and apparatus for optical imaging via spectral encoding
US7889348B2 (en) 2005-10-14 2011-02-15 The General Hospital Corporation Arrangements and methods for facilitating photoluminescence imaging
US20070263208A1 (en) * 2006-01-10 2007-11-15 The General Hospital Corporation Systems and methods for generating data based on one or more spectrally-encoded endoscopy techniques
US7796270B2 (en) 2006-01-10 2010-09-14 The General Hospital Corporation Systems and methods for generating data based on one or more spectrally-encoded endoscopy techniques
US20070238955A1 (en) * 2006-01-18 2007-10-11 The General Hospital Corporation Systems and methods for generating data using one or more endoscopic microscopy techniques
US9791317B2 (en) 2006-01-19 2017-10-17 The General Hospital Corporation Spectrally-encoded endoscopy techniques and methods
US9087368B2 (en) 2006-01-19 2015-07-21 The General Hospital Corporation Methods and systems for optical imaging or epithelial luminal organs by beam scanning thereof
US9516997B2 (en) 2006-01-19 2016-12-13 The General Hospital Corporation Spectrally-encoded endoscopy techniques, apparatus and methods
US8145018B2 (en) 2006-01-19 2012-03-27 The General Hospital Corporation Apparatus for obtaining information for a structure using spectrally-encoded endoscopy techniques and methods for producing one or more optical arrangements
US9646377B2 (en) 2006-01-19 2017-05-09 The General Hospital Corporation Methods and systems for optical imaging or epithelial luminal organs by beam scanning thereof
US8818149B2 (en) 2006-01-19 2014-08-26 The General Hospital Corporation Spectrally-encoded endoscopy techniques, apparatus and methods
US10987000B2 (en) 2006-01-19 2021-04-27 The General Hospital Corporation Methods and systems for optical imaging or epithelial luminal organs by beam scanning thereof
US9186067B2 (en) 2006-02-01 2015-11-17 The General Hospital Corporation Apparatus for applying a plurality of electro-magnetic radiations to a sample
US9186066B2 (en) 2006-02-01 2015-11-17 The General Hospital Corporation Apparatus for applying a plurality of electro-magnetic radiations to a sample
US20070177152A1 (en) * 2006-02-01 2007-08-02 The General Hospital Corporation Methods and systems for monitoring and obtaining information of at least one portion of a sample using conformal laser therapy procedures, and providing electromagnetic radiation thereto
US10426548B2 (en) 2006-02-01 2019-10-01 The General Hosppital Corporation Methods and systems for providing electromagnetic radiation to at least one portion of a sample using conformal laser therapy procedures
US9777053B2 (en) 2006-02-08 2017-10-03 The General Hospital Corporation Methods, arrangements and systems for obtaining information associated with an anatomical sample using optical microscopy
USRE46412E1 (en) 2006-02-24 2017-05-23 The General Hospital Corporation Methods and systems for performing angle-resolved Fourier-domain optical coherence tomography
US7982879B2 (en) 2006-02-24 2011-07-19 The General Hospital Corporation Methods and systems for performing angle-resolved fourier-domain optical coherence tomography
US7742173B2 (en) 2006-04-05 2010-06-22 The General Hospital Corporation Methods, arrangements and systems for polarization-sensitive optical frequency domain imaging of a sample
US9364143B2 (en) 2006-05-10 2016-06-14 The General Hospital Corporation Process, arrangements and systems for providing frequency domain imaging of a sample
US8175685B2 (en) 2006-05-10 2012-05-08 The General Hospital Corporation Process, arrangements and systems for providing frequency domain imaging of a sample
US10413175B2 (en) 2006-05-10 2019-09-17 The General Hospital Corporation Process, arrangements and systems for providing frequency domain imaging of a sample
US7782464B2 (en) 2006-05-12 2010-08-24 The General Hospital Corporation Processes, arrangements and systems for providing a fiber layer thickness map based on optical coherence tomography images
US7920271B2 (en) 2006-08-25 2011-04-05 The General Hospital Corporation Apparatus and methods for enhancing optical coherence tomography imaging using volumetric filtering techniques
US9968245B2 (en) 2006-10-19 2018-05-15 The General Hospital Corporation Apparatus and method for obtaining and providing imaging information associated with at least one portion of a sample, and effecting such portion(s)
US8838213B2 (en) 2006-10-19 2014-09-16 The General Hospital Corporation Apparatus and method for obtaining and providing imaging information associated with at least one portion of a sample, and effecting such portion(s)
US7949019B2 (en) 2007-01-19 2011-05-24 The General Hospital Wavelength tuning source based on a rotatable reflector
US9176319B2 (en) 2007-03-23 2015-11-03 The General Hospital Corporation Methods, arrangements and apparatus for utilizing a wavelength-swept laser using angular scanning and dispersion procedures
US10534129B2 (en) 2007-03-30 2020-01-14 The General Hospital Corporation System and method providing intracoronary laser speckle imaging for the detection of vulnerable plaque
US8045177B2 (en) 2007-04-17 2011-10-25 The General Hospital Corporation Apparatus and methods for measuring vibrations using spectrally-encoded endoscopy
US8115919B2 (en) 2007-05-04 2012-02-14 The General Hospital Corporation Methods, arrangements and systems for obtaining information associated with a sample using optical microscopy
US20090323056A1 (en) * 2007-05-04 2009-12-31 The General Hospital Corporation Methods, arrangements and systems for obtaining information associated with a sample using optical microscopy
US9375158B2 (en) 2007-07-31 2016-06-28 The General Hospital Corporation Systems and methods for providing beam scan patterns for high speed doppler optical frequency domain imaging
US8040608B2 (en) 2007-08-31 2011-10-18 The General Hospital Corporation System and method for self-interference fluorescence microscopy, and computer-accessible medium associated therewith
US7933021B2 (en) 2007-10-30 2011-04-26 The General Hospital Corporation System and method for cladding mode detection
US20090273777A1 (en) * 2008-04-30 2009-11-05 The General Hospital Corporation Apparatus and method for cross axis parallel spectroscopy
US7898656B2 (en) 2008-04-30 2011-03-01 The General Hospital Corporation Apparatus and method for cross axis parallel spectroscopy
US9173572B2 (en) 2008-05-07 2015-11-03 The General Hospital Corporation System, method and computer-accessible medium for tracking vessel motion during three-dimensional coronary artery microscopy
US8593619B2 (en) 2008-05-07 2013-11-26 The General Hospital Corporation System, method and computer-accessible medium for tracking vessel motion during three-dimensional coronary artery microscopy
US8861910B2 (en) 2008-06-20 2014-10-14 The General Hospital Corporation Fused fiber optic coupler arrangement and method for use thereof
US10835110B2 (en) 2008-07-14 2020-11-17 The General Hospital Corporation Apparatus and method for facilitating at least partial overlap of dispersed ration on at least one sample
US9254089B2 (en) 2008-07-14 2016-02-09 The General Hospital Corporation Apparatus and methods for facilitating at least partial overlap of dispersed ration on at least one sample
US20100150422A1 (en) * 2008-12-10 2010-06-17 The General Hospital Corporation Systems and Methods for Extending Imaging Depth Range of Optical Coherence Tomography Through Optical Sub-Sampling
US8937724B2 (en) 2008-12-10 2015-01-20 The General Hospital Corporation Systems and methods for extending imaging depth range of optical coherence tomography through optical sub-sampling
US9615748B2 (en) 2009-01-20 2017-04-11 The General Hospital Corporation Endoscopic biopsy apparatus, system and method
US8097864B2 (en) 2009-01-26 2012-01-17 The General Hospital Corporation System, method and computer-accessible medium for providing wide-field superresolution microscopy
US9351642B2 (en) 2009-03-12 2016-05-31 The General Hospital Corporation Non-contact optical system, computer-accessible medium and method for measurement at least one mechanical property of tissue using coherent speckle technique(s)
US11490826B2 (en) 2009-07-14 2022-11-08 The General Hospital Corporation Apparatus, systems and methods for measuring flow and pressure within a vessel
US9081148B2 (en) 2010-03-05 2015-07-14 The General Hospital Corporation Systems, methods and computer-accessible medium which provide microscopic images of at least one anatomical structure at a particular resolution
US8804126B2 (en) 2010-03-05 2014-08-12 The General Hospital Corporation Systems, methods and computer-accessible medium which provide microscopic images of at least one anatomical structure at a particular resolution
US8896838B2 (en) 2010-03-05 2014-11-25 The General Hospital Corporation Systems, methods and computer-accessible medium which provide microscopic images of at least one anatomical structure at a particular resolution
US10463254B2 (en) 2010-03-05 2019-11-05 The General Hospital Corporation Light tunnel and lens which provide extended focal depth of at least one anatomical structure at a particular resolution
US9408539B2 (en) 2010-03-05 2016-08-09 The General Hospital Corporation Systems, methods and computer-accessible medium which provide microscopic images of at least one anatomical structure at a particular resolution
US9642531B2 (en) 2010-03-05 2017-05-09 The General Hospital Corporation Systems, methods and computer-accessible medium which provide microscopic images of at least one anatomical structure at a particular resolution
US9069130B2 (en) 2010-05-03 2015-06-30 The General Hospital Corporation Apparatus, method and system for generating optical radiation from biological gain media
US9951269B2 (en) 2010-05-03 2018-04-24 The General Hospital Corporation Apparatus, method and system for generating optical radiation from biological gain media
US9795301B2 (en) 2010-05-25 2017-10-24 The General Hospital Corporation Apparatus, systems, methods and computer-accessible medium for spectral analysis of optical coherence tomography images
US10939825B2 (en) 2010-05-25 2021-03-09 The General Hospital Corporation Systems, devices, methods, apparatus and computer-accessible media for providing optical imaging of structures and compositions
US9557154B2 (en) 2010-05-25 2017-01-31 The General Hospital Corporation Systems, devices, methods, apparatus and computer-accessible media for providing optical imaging of structures and compositions
US10285568B2 (en) 2010-06-03 2019-05-14 The General Hospital Corporation Apparatus and method for devices for imaging structures in or at one or more luminal organs
US9510758B2 (en) 2010-10-27 2016-12-06 The General Hospital Corporation Apparatus, systems and methods for measuring blood pressure within at least one vessel
US9330092B2 (en) 2011-07-19 2016-05-03 The General Hospital Corporation Systems, methods, apparatus and computer-accessible-medium for providing polarization-mode dispersion compensation in optical coherence tomography
US10241028B2 (en) 2011-08-25 2019-03-26 The General Hospital Corporation Methods, systems, arrangements and computer-accessible medium for providing micro-optical coherence tomography procedures
US9341783B2 (en) 2011-10-18 2016-05-17 The General Hospital Corporation Apparatus and methods for producing and/or providing recirculating optical delay(s)
US9629528B2 (en) 2012-03-30 2017-04-25 The General Hospital Corporation Imaging system, method and distal attachment for multidirectional field of view endoscopy
US11490797B2 (en) 2012-05-21 2022-11-08 The General Hospital Corporation Apparatus, device and method for capsule microscopy
US9968261B2 (en) 2013-01-28 2018-05-15 The General Hospital Corporation Apparatus and method for providing diffuse spectroscopy co-registered with optical frequency domain imaging
US10893806B2 (en) 2013-01-29 2021-01-19 The General Hospital Corporation Apparatus, systems and methods for providing information regarding the aortic valve
US11179028B2 (en) 2013-02-01 2021-11-23 The General Hospital Corporation Objective lens arrangement for confocal endomicroscopy
US9784681B2 (en) 2013-05-13 2017-10-10 The General Hospital Corporation System and method for efficient detection of the phase and amplitude of a periodic modulation associated with self-interfering fluorescence
US10117576B2 (en) 2013-07-19 2018-11-06 The General Hospital Corporation System, method and computer accessible medium for determining eye motion by imaging retina and providing feedback for acquisition of signals from the retina
US11452433B2 (en) 2013-07-19 2022-09-27 The General Hospital Corporation Imaging apparatus and method which utilizes multidirectional field of view endoscopy
US10058250B2 (en) 2013-07-26 2018-08-28 The General Hospital Corporation System, apparatus and method for utilizing optical dispersion for fourier-domain optical coherence tomography
US9668652B2 (en) 2013-07-26 2017-06-06 The General Hospital Corporation System, apparatus and method for utilizing optical dispersion for fourier-domain optical coherence tomography
US9733460B2 (en) 2014-01-08 2017-08-15 The General Hospital Corporation Method and apparatus for microscopic imaging
US10736494B2 (en) 2014-01-31 2020-08-11 The General Hospital Corporation System and method for facilitating manual and/or automatic volumetric imaging with real-time tension or force feedback using a tethered imaging device
US10228556B2 (en) 2014-04-04 2019-03-12 The General Hospital Corporation Apparatus and method for controlling propagation and/or transmission of electromagnetic radiation in flexible waveguide(s)
US10912462B2 (en) 2014-07-25 2021-02-09 The General Hospital Corporation Apparatus, devices and methods for in vivo imaging and diagnosis

Also Published As

Publication number Publication date
GB947609A (en) 1964-01-22

Similar Documents

Publication Publication Date Title
US3090753A (en) Ester oil compositions containing acid anhydride
US3180832A (en) Oil compositions containing anti-wear additives
US3185644A (en) Lubricating compositions containing amine salts of boron-containing compounds
US3660290A (en) Lubricant compositions
US3573206A (en) Lubricant compositions
US3360465A (en) Synthetic ester lubricants
US2798083A (en) Synthetic ester lubricants
US4048082A (en) Organic lubricating compositions containing esters of benzotriazole
US4698169A (en) Reaction products of alkenylsuccinic compounds with aromatic amines and lubricant compositions thereof
FI85159B (en) I SMOERJMEDEL ANVAENDBAR REAKTIONSPRODUKT AV TRIAXOL OCH AMINFOSFAT.
US3019188A (en) Lubricating oil compositions containing esters of polycarboxylic aromatic acids
US3535243A (en) Stable synthetic ester lubricant compositions
US4803004A (en) Reaction products of alkenylsuccinic compounds with aromatic amines and hindered alcohols and lubricant compositions thereof
US3148147A (en) 2, 2-dialkyl-1, 3-propanediol diesters as functional fluids
US3296136A (en) Lubricant compositions of improved oxidation resistance
US3029204A (en) Acidic partial esters as lubricating oil additives
US2820766A (en) Lubricating compositions
US3804762A (en) Antioxidants
US2889281A (en) Synthetic lubricating composition
US3554945A (en) Lubricating compositions containing alkylated polyhydroxy aromatic compounds
US2644793A (en) Rust inhibiting composition
US3223636A (en) Lead corrosion inhibitor
US3761405A (en) Anti oxidants
US3287270A (en) Lubricants and fuels containing boroxarophenanthrene compounds
US3337457A (en) Crankcase lubricants comprising a mineral and synthetic ester oil blend